BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sasako M, Sano T, Yamamoto S, Kurokawa Y, Nashimoto A, Kurita A, Hiratsuka M, Tsujinaka T, Kinoshita T, Arai K, Yamamura Y, Okajima K; Japan Clinical Oncology Group. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med. 2008;359:453-462. [PMID: 18669424 DOI: 10.1056/nejmoa0707035] [Cited by in Crossref: 622] [Cited by in F6Publishing: 311] [Article Influence: 44.4] [Reference Citation Analysis]
Number Citing Articles
1 Chen YR, Chen YL, Ouyang SS, Xu HW, Li P, He LJ, Zhu SL. Prognostic efficacy of preoperative mGPS, SIS and LCS in patients with gastric cancer. Clin Chim Acta 2020;511:81-9. [PMID: 33002476 DOI: 10.1016/j.cca.2020.09.027] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Pugliese R, Maggioni D, Sansonna F, Costanzi A, Ferrari GC, Di Lernia S, Magistro C, De Martini P, Pugliese F. Subtotal gastrectomy with D2 dissection by minimally invasive surgery for distal adenocarcinoma of the stomach: results and 5-year survival. Surg Endosc 2010;24:2594-602. [PMID: 20414682 DOI: 10.1007/s00464-010-1014-1] [Cited by in Crossref: 101] [Cited by in F6Publishing: 93] [Article Influence: 8.4] [Reference Citation Analysis]
3 Dikken JL, van de Velde CJ, Coit DG, Shah MA, Verheij M, Cats A. Treatment of resectable gastric cancer. Therap Adv Gastroenterol. 2012;5:49-69. [PMID: 22282708 DOI: 10.1177/1756283x11410771] [Cited by in Crossref: 48] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
4 Liang H, Deng J. Evaluation of rational extent lymphadenectomy for local advanced gastric cancer. Chin J Cancer Res. 2016;28:397-403. [PMID: 27647967 DOI: 10.21147/j.issn.1000-9604.2016.04.02] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
5 Brenkman HJ, Haverkamp L, Ruurda JP, van Hillegersberg R. Worldwide practice in gastric cancer surgery. World J Gastroenterol 2016; 22(15): 4041-4048 [PMID: 27099448 DOI: 10.3748/wjg.v22.i15.4041] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 36] [Article Influence: 6.2] [Reference Citation Analysis]
6 Kim Y, Kim KM, Choi MG, Lee JH, Sohn TS, Bae JM, Kim S, Lee SJ, Kim ST, Lee J, Park JO, Park YS, Lim HY, Kang WK, Park SH. Adjuvant Chemotherapy with or without Concurrent Radiotherapy for Patients with Stage IB Gastric Cancer: a Subgroup Analysis of the Adjuvant Chemoradiotherapy in Stomach Tumors (ARTIST) Phase III Trial. J Gastric Cancer 2018;18:348-55. [PMID: 30607298 DOI: 10.5230/jgc.2018.18.e34] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
7 Guner A, Hyung WJ. Advantages of Splenic Hilar Lymph Node Dissection in Proximal Gastric Cancer Surgery. J Gastric Cancer 2020;20:19-28. [PMID: 32269841 DOI: 10.5230/jgc.2020.20.e10] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Hashimoto T, Kurokawa Y, Mori M, Doki Y. Update on the Treatment of Gastric Cancer. JMA J 2018;1:40-9. [PMID: 33748521 DOI: 10.31662/jmaj.2018-0006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
9 Jiang K, Liu H, Xie D, Xiao Q. Differentially expressed genes ASPN, COL1A1, FN1, VCAN and MUC5AC are potential prognostic biomarkers for gastric cancer. Oncol Lett 2019;17:3191-202. [PMID: 30867749 DOI: 10.3892/ol.2019.9952] [Cited by in Crossref: 16] [Cited by in F6Publishing: 26] [Article Influence: 5.3] [Reference Citation Analysis]
10 Abbas MN, Bright T, Price T, Karapetis C, Thompson S, Connell C, Watson D, Barnes M, Bull J, Singhal N, Roy A. Patterns of care and outcomes for gastric and gastro-oesophageal junction cancer in an Australian population. ANZ J Surg 2021. [PMID: 34617383 DOI: 10.1111/ans.17249] [Reference Citation Analysis]
11 Kanda M, Kobayashi D, Tanaka C, Iwata N, Yamada S, Fujii T, Nakayama G, Sugimoto H, Koike M, Nomoto S, Murotani K, Fujiwara M, Kodera Y. Adverse prognostic impact of perioperative allogeneic transfusion on patients with stage II/III gastric cancer. Gastric Cancer. 2016;19:255-263. [PMID: 25563579 DOI: 10.1007/s10120-014-0456-x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 7.0] [Reference Citation Analysis]
12 Meyer HJ, Hölscher AH, Lordick F, Messmann H, Mönig S, Schumacher C, Stahl M, Wilke H, Möhler M. [Current S3 guidelines on surgical treatment of gastric carcinoma]. Chirurg 2012;83:31-7. [PMID: 22127381 DOI: 10.1007/s00104-011-2149-x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 3.2] [Reference Citation Analysis]
13 Mata DA, Groshen S, Von Rundstedt FC, Skinner DG, Stadler WM, Cote RJ, Stein JP, Lerner SP. Variability in surgical quality in a phase III clinical trial of radical cystectomy in patients with organ-confined, node-negative urothelial carcinoma of the bladder. J Surg Oncol 2015;111:923-8. [PMID: 25873574 DOI: 10.1002/jso.23903] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
14 Xing YN, Deng P, Xu HM. Canstatin induces apoptosis in gastric cancer xenograft growth in mice through the mitochondrial apoptotic pathway. Biosci Rep 2014;34:e00106. [PMID: 27919040 DOI: 10.1042/BSR20140012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
15 Hartgrink HH, Jansen EP, van Grieken NC, van de Velde CJ. Gastric cancer. Lancet. 2009;374:477-490. [PMID: 19625077 DOI: 10.1016/s0140-6736(09)60617-6] [Cited by in Crossref: 635] [Cited by in F6Publishing: 407] [Article Influence: 48.8] [Reference Citation Analysis]
16 Wu F, Shi C, Wu R, Huang Z, Chen Q. Peritoneal recurrence in gastric cancer following curative resection can be predicted by postoperative but not preoperative biomarkers: a single-institution study of 320 cases. Oncotarget 2017;8:78120-32. [PMID: 29100454 DOI: 10.18632/oncotarget.17696] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
17 Deng J, Liang H, Sun D, Pan Y, Liu Y, Wang D. Extended lymphadenectomy improvement of overall survival of gastric cancer patients with perigastric node metastasis. Langenbecks Arch Surg. 2011;396:615-623. [PMID: 21380618 DOI: 10.1007/s00423-011-0753-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
18 Kim S, Kim YS, Kim JH, Min YD, Hong R. Early gastric cancer with neurofibroma mimicking a metastatic node: a case report. J Gastric Cancer 2013;13:185-7. [PMID: 24156039 DOI: 10.5230/jgc.2013.13.3.185] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
19 Marrelli D, Polom K, de Manzoni G, Morgagni P, Baiocchi GL, Roviello F. Multimodal treatment of gastric cancer in the west: Where are we going? World J Gastroenterol 2015; 21(26): 7954-7969 [PMID: 26185368 DOI: 10.3748/wjg.v21.i26.7954] [Cited by in CrossRef: 39] [Cited by in F6Publishing: 42] [Article Influence: 5.6] [Reference Citation Analysis]
20 Morgagni P, Tringali D, La Barba G, Vittimberga G, Ercolani G. Historical assumptions of lymphadenectomy. Transl Gastroenterol Hepatol 2016;1:90. [PMID: 28138655 DOI: 10.21037/tgh.2016.11.06] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
21 Liu X, Sun X, Liu J, Kong P, Chen S, Zhan Y, Xu D. Preoperative C-Reactive Protein/Albumin Ratio Predicts Prognosis of Patients after Curative Resection for Gastric Cancer. Transl Oncol. 2015;8:339-345. [PMID: 26310380 DOI: 10.1016/j.tranon.2015.06.006] [Cited by in Crossref: 93] [Cited by in F6Publishing: 104] [Article Influence: 13.3] [Reference Citation Analysis]
22 Miki Y, Tokunaga M, Bando E, Tanizawa Y, Kawamura T, Terashima M. Evaluation of postoperative pancreatic fistula after total gastrectomy with D2 lymphadenectomy by ISGPF classification. J Gastrointest Surg. 2011;15:1969-1976. [PMID: 21833745 DOI: 10.1007/s11605-011-1628-1] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.5] [Reference Citation Analysis]
23 Liu M, Xing J, Xu K, Yuan P, Cui M, Zhang C, Yang H, Yao Z, Zhang N, Tan F, Su X. Application of Near-Infrared Fluorescence Imaging with Indocyanine Green in Totally Laparoscopic Distal Gastrectomy. J Gastric Cancer 2020;20:290-9. [PMID: 33024585 DOI: 10.5230/jgc.2020.20.e25] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Pan S, Wang P, Xing Y, Li K, Wang Z, Xu H, Zhu Z. Retrieved lymph nodes from different anatomic groups in gastric cancer: a proposed optimal number, comparison with other nodal classification strategies and its impact on prognosis. Cancer Commun (Lond) 2019;39:49. [PMID: 31519217 DOI: 10.1186/s40880-019-0394-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
25 Kim MR, Kim AS, Choi HI, Jung JH, Park JY, Ko HJ. Inflammatory markers for predicting overall survival in gastric cancer patients: A systematic review and meta-analysis. PLoS One 2020;15:e0236445. [PMID: 32716955 DOI: 10.1371/journal.pone.0236445] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
26 Matsuyama J, Terazawa T, Goto M, Kawabata R, Endo S, Imano M, Fujita S, Akamaru Y, Taniguchi H, Tatsumi M, Lee S, Kawakami H, Kurokawa Y, Shimokawa T, Sakai D, Kato T, Fujitani K, Satoh T. Three-Year Outcomes of a Phase II Study of Perioperative Capecitabine Plus Oxaliplatin Therapy for Clinical SS/SE N1-3 M0 Gastric Cancer (OGSG 1601). The Oncologist 2022;27:251-e304. [DOI: 10.1093/oncolo/oyab061] [Reference Citation Analysis]
27 Sharma A, Radhakrishnan V. Gastric cancer in India. Indian J Med Paediatr Oncol 2021;32:12-6. [DOI: 10.4103/0971-5851.81884] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
28 Strong VE, Yoon SS. Extended lymphadenectomy in gastric cancer is debatable. World J Surg. 2013;37:1773-1777. [PMID: 23649527 DOI: 10.1007/s00268-013-2070-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
29 Lurje G, Husain H, Power DG, Yang D, Groshen S, Pohl A, Zhang W, Ning Y, Manegold PC, El-Khoueiry A. Genetic variations in angiogenesis pathway genes associated with clinical outcome in localized gastric adenocarcinoma. Ann Oncol. 2010;21:78-86. [PMID: 19622587 DOI: 10.1093/annonc/mdp280] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 2.5] [Reference Citation Analysis]
30 Feng D, Leong M, Li T, Chen L. Surgical outcomes in patients with locally advanced gastric cancer treated with S-1 and oxaliplatin as neoadjuvant chemotherapy. World J Surg Oncol. 2015;13:11. [PMID: 25634099 DOI: 10.1186/s12957-015-0444-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
31 Akagi T, Shiraishi N, Kitano S. Lymph node metastasis of gastric cancer. Cancers (Basel). 2011;3:2141-2159. [PMID: 24212800 DOI: 10.3390/cancers3022141] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 2.7] [Reference Citation Analysis]
32 Xie D, Shen J, Liu L, Cao B, Wang Y, Qin J, Wu J, Yan Q, Hu Y, Yang C, Cao Z, Hu J, Yin P, Gong J. Complete mesogastric excision for locally advanced gastric cancer: short-term outcomes of a randomized clinical trial. Cell Rep Med 2021;2:100217. [PMID: 33763656 DOI: 10.1016/j.xcrm.2021.100217] [Reference Citation Analysis]
33 Jomrich G, Schoppmann SF. Targeted therapy in gastric cancer. Eur Surg 2016;48:278-84. [PMID: 27795701 DOI: 10.1007/s10353-016-0389-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
34 Hiura Y, Takiguchi S, Yamamoto K, Kurokawa Y, Yamasaki M, Nakajima K, Miyata H, Fujiwara Y, Mori M, Doki Y. Use of fibrin glue sealant with polyglycolic acid sheets to prevent pancreatic fistula formation after laparoscopic-assisted gastrectomy. Surg Today. 2013;43:527-533. [PMID: 22797962 DOI: 10.1007/s00595-012-0253-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
35 Batista TP, Martins MR. Lymph node dissection for gastric cancer: a critical review. Oncol Rev 2012;6:e12. [PMID: 25992202 DOI: 10.4081/oncol.2012.e12] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
36 Saito M, Kiyozaki H, Takata O, Suzuki K, Rikiyama T. Treatment of stage IV gastric cancer with induction chemotherapy using S-1 and cisplatin followed by curative resection in selected patients. World J Surg Oncol. 2014;12:406. [PMID: 25551581 DOI: 10.1186/1477-7819-12-406] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
37 Liu X, Qiu H, Liu J, Chen S, Xu D, Li W, Zhan Y, Li Y, Chen Y, Zhou Z, Sun X. Combined preoperative concentrations of CEA, CA 19-9, and 72-4 for predicting outcomes in patients with gastric cancer after curative resection. Oncotarget. 2016;7:35446-35453. [PMID: 27147574 DOI: 10.18632/oncotarget.9060] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
38 Kavaliauskas P, Maziukas R, Samalavicius NE, Kuliavas J, Lunevicius R. Subtotal gastrectomy with conventional D2 lymphadenectomy for carcinoma of the distal gastric portion: A retrospective cohort study on clinical outcomes. Ann Med Surg (Lond) 2016;6:36-41. [PMID: 27141301 DOI: 10.1016/j.amsu.2016.01.023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
39 Takahashi T, Saikawa Y, Kitagawa Y. Gastric cancer: current status of diagnosis and treatment. Cancers (Basel). 2013;5:48-63. [PMID: 24216698 DOI: 10.3390/cancers5010048] [Cited by in Crossref: 102] [Cited by in F6Publishing: 105] [Article Influence: 11.3] [Reference Citation Analysis]
40 Nagem R, Bicalho LG, Lourenço LG. Surgical treatment of gastric cancer in a community hospital in Brazil: who are we treating and how? J Gastrointest Cancer 2013;44:410-6. [PMID: 23812916 DOI: 10.1007/s12029-013-9516-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
41 Imamura T, Komatsu S, Ichikawa D, Kosuga T, Okamoto K, Konishi H, Shiozaki A, Fujiwara H, Otsuji E. Clinical characteristics of hepatoduodenal lymph node metastasis in gastric cancer. World J Gastroenterol 2015; 21(38): 10866-10873 [PMID: 26478677 DOI: 10.3748/wjg.v21.i38.10866] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
42 Shiozaki H, Shimodaira Y, Elimova E, Wadhwa R, Sudo K, Harada K, Estrella JS, Das P, Badgwell B, Ajani JA. Evolution of gastric surgery techniques and outcomes. Chin J Cancer 2016;35:69. [PMID: 27460019 DOI: 10.1186/s40880-016-0134-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
43 Foo M, Leong T. Adjuvant therapy for gastric cancer: Current and future directions. World J Gastroenterol 2014; 20(38): 13718-13727 [PMID: 25320509 DOI: 10.3748/wjg.v20.i38.13718] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
44 Brisinda G, Chiarello MM, Crocco A, Adams NJ, Fransvea P, Vanella S. Postoperative mortality and morbidity after D2 lymphadenectomy for gastric cancer: A retrospective cohort study. World J Gastroenterol 2022;28:381-98. [PMID: 35110956 DOI: 10.3748/wjg.v28.i3.381] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
45 Mine S. Is the length of esophageal invasion only associated with mediastinal nodal metastasis from adenocarcinoma of the esophagogastric junction (Siewert type II and III) after neo-adjuvant chemoradiotherapy? J Thorac Dis 2019;11:E152-3. [PMID: 31737326 DOI: 10.21037/jtd.2019.09.78] [Reference Citation Analysis]
46 Ito S, Sano T, Mizusawa J, Takahari D, Katayama H, Katai H, Kawashima Y, Kinoshita T, Terashima M, Nashimoto A, Nakamori M, Onaya H, Sasako M. A phase II study of preoperative chemotherapy with docetaxel, cisplatin, and S-1 followed by gastrectomy with D2 plus para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis: JCOG1002. Gastric Cancer. 2017;20:322-331. [PMID: 27299887 DOI: 10.1007/s10120-016-0619-z] [Cited by in Crossref: 52] [Cited by in F6Publishing: 52] [Article Influence: 8.7] [Reference Citation Analysis]
47 Ojima T, Iwahashi M, Nakamori M, Nakamura M, Naka T, Katsuda M, Iida T, Hayata K, Yamaue H. Association of allogeneic blood transfusions and long-term survival of patients with gastric cancer after curative gastrectomy. J Gastrointest Surg. 2009;13:1821-1830. [PMID: 19655208 DOI: 10.1007/s11605-009-0973-9] [Cited by in Crossref: 60] [Cited by in F6Publishing: 56] [Article Influence: 4.6] [Reference Citation Analysis]
48 Gholami S, Janson L, Worhunsky DJ, Tran TB, Squires MH 3rd, Jin LX, Spolverato G, Votanopoulos KI, Schmidt C, Weber SM, Bloomston M, Cho CS, Levine EA, Fields RC, Pawlik TM, Maithel SK, Efron B, Norton JA, Poultsides GA. Number of Lymph Nodes Removed and Survival after Gastric Cancer Resection: An Analysis from the US Gastric Cancer Collaborative. J Am Coll Surg. 2015;221:291-299. [PMID: 26206635 DOI: 10.1016/j.jamcollsurg.2015.04.024] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 5.9] [Reference Citation Analysis]
49 Hu Y, Yoon SS. Extent of gastrectomy and lymphadenectomy for gastric adenocarcinoma. Surg Oncol 2021;40:101689. [PMID: 34839198 DOI: 10.1016/j.suronc.2021.101689] [Reference Citation Analysis]
50 Panda SK, Sahoo PK, Agarwala SK, Houghton T T, Chandrapattan PP, Sankar K V, Nag R. Evolution of treatment in gastric cancer- a systematic review. J Egypt Natl Canc Inst 2022;34:12. [PMID: 35307789 DOI: 10.1186/s43046-022-00114-7] [Reference Citation Analysis]
51 Okugawa Y, Toiyama Y, Hur K, Toden S, Saigusa S, Tanaka K, Inoue Y, Mohri Y, Kusunoki M, Boland CR. Metastasis-associated long non-coding RNA drives gastric cancer development and promotes peritoneal metastasis. Carcinogenesis. 2014;35:2731-2739. [PMID: 25280565 DOI: 10.1093/carcin/bgu200] [Cited by in Crossref: 148] [Cited by in F6Publishing: 161] [Article Influence: 18.5] [Reference Citation Analysis]
52 Kumar S, Kumar N, Deo S, Bhoriwal S, Mandal A, Sharma A, Pathy S, Das P, Thulkar S, Bhatnagar S. Patterns of Multimodality Management of Gastric Cancer—Single Institutional Experience of 372 Cases From a Tertiary Care Center in North India. Front Oncol 2022;12:877493. [DOI: 10.3389/fonc.2022.877493] [Reference Citation Analysis]
53 Tamura S, Takeno A, Miki H. Lymph node dissection in curative gastrectomy for advanced gastric cancer. Int J Surg Oncol. 2011;2011:748745. [PMID: 22312521 DOI: 10.1155/2011/748745] [Cited by in Crossref: 9] [Cited by in F6Publishing: 21] [Article Influence: 0.8] [Reference Citation Analysis]
54 Han FH, Zhou SN, Li HM, He YL, Zhan WH. Vascularizing lymph node dissection for advanced gastric cancer: A single-institution experience. World J Gastroenterol 2016; 22(14): 3813-3820 [PMID: 27076766 DOI: 10.3748/wjg.v22.i14.3813] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
55 Stewart C, Chao J, Chen YJ, Lin J, Sullivan MJ, Melstrom L, Hyung WJ, Fong Y, Paz IB, Woo Y. Multimodality management of locally advanced gastric cancer-the timing and extent of surgery. Transl Gastroenterol Hepatol 2019;4:42. [PMID: 31231709 DOI: 10.21037/tgh.2019.05.02] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
56 Kikuchi S, Kubota T, Kuroda S, Nishizaki M, Kagawa S, Kato H, Okada H, Fujiwara T. Endoscopic Ultrasound-Guided Transgastric Drainage of an IntraAbdominal Abscess following Gastrectomy. Clin Endosc 2019;52:373-6. [PMID: 30764599 DOI: 10.5946/ce.2018.134] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
57 Zhang J, Feng G, Yang Y, Zhang P, Pu C, Zhao G. Acute kidney injury after radical gastrectomy: a single center study. Int Urol Nephrol 2014;46:973-7. [PMID: 24318368 DOI: 10.1007/s11255-013-0618-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
58 Suh BJ. A Case of Advanced Gastric Cancer with Para-Aortic Lymph Node Metastasis Treated with Preoperative FOLFOX Chemotherapy Followed by Radical Subtotal Gastrectomy and D2 Lymph Node Dissection. Case Rep Oncol 2017;10:182-91. [PMID: 28413395 DOI: 10.1159/000457791] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
59 Aoyama T, Nakazono M, Nagasawa S, Segami K. Clinical Impact of a Perioperative Exercise Program for Sarcopenia and Overweight/Obesity Gastric Cancer. In Vivo 2021;35:707-12. [PMID: 33622863 DOI: 10.21873/invivo.12311] [Reference Citation Analysis]
60 Ushida Y, Hiramatsu K, Saeki S, Amemiya T, Goto H, Arai T. Long-term survival of a patient with advanced gastric cancer with paraaortic lymph node metastasis who attained pathological complete response after S-1/CDDP chemotherapy: A case report. Int J Surg Case Rep 2017;39:260-3. [PMID: 28881333 DOI: 10.1016/j.ijscr.2017.08.016] [Reference Citation Analysis]
61 Deng J, Zhang R, Pan Y, Wang B, Wu L, Hao X, Liang H. N stages of the seventh edition of TNM Classification are the most intensive variables for predictions of the overall survival of gastric cancer patients who underwent limited lymphadenectomy. Tumour Biol 2014;35:3269-81. [PMID: 24293375 DOI: 10.1007/s13277-013-1428-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
62 Tokunaga M, Sato Y, Nakagawa M, Aburatani T, Matsuyama T, Nakajima Y, Kinugasa Y. Perioperative chemotherapy for locally advanced gastric cancer in Japan: current and future perspectives. Surg Today. 2020;50:30-37. [PMID: 31612329 DOI: 10.1007/s00595-019-01896-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
63 Xiao H, Xiao Y, Chen P, Quan H, Luo J, Huang G. Association Among Blood Transfusion, Postoperative Infectious Complications, and Cancer-Specific Survival in Patients with Stage II/III Gastric Cancer After Radical Gastrectomy: Emphasizing Benefit from Adjuvant Chemotherapy. Ann Surg Oncol 2021;28:2394-404. [PMID: 32929601 DOI: 10.1245/s10434-020-09102-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
64 Deng JY, Liang H. Clinical significance of lymph node metastasis in gastric cancer. World J Gastroenterol 2014; 20(14): 3967-3975 [PMID: 24744586 DOI: 10.3748/wjg.v20.i14.3967] [Cited by in CrossRef: 80] [Cited by in F6Publishing: 80] [Article Influence: 10.0] [Reference Citation Analysis]
65 Chen D, Liu Z, Liu W, Fu M, Jiang W, Xu S, Wang G, Chen F, Lu J, Chen H, Dong X, Li G, Chen G, Zhuo S, Yan J. Predicting postoperative peritoneal metastasis in gastric cancer with serosal invasion using a collagen nomogram. Nat Commun 2021;12:179. [PMID: 33420057 DOI: 10.1038/s41467-020-20429-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
66 Kodera Y. Neoadjuvant chemotherapy for gastric adenocarcinoma in Japan. Surg Today. 2017;47:899-907. [PMID: 28247105 DOI: 10.1007/s00595-017-1473-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
67 Kobayakawa M, Kojima Y. Tegafur/gimeracil/oteracil (S-1) approved for the treatment of advanced gastric cancer in adults when given in combination with cisplatin: a review comparing it with other fluoropyrimidine-based therapies. Onco Targets Ther. 2011;4:193-201. [PMID: 22162925 DOI: 10.2147/ott.s19059] [Cited by in Crossref: 32] [Cited by in F6Publishing: 17] [Article Influence: 2.9] [Reference Citation Analysis]
68 Ohnuma H, Sato Y, Onoyama N, Hamaguchi K, Hayasaka N, Sato M, Murase K, Takada K, Miyanishi K, Murakami T, Ito T, Nobuoka T, Takemasa I, Kato J. Survival benefit of conversion surgery after intensive chemotherapy for unresectable metastatic gastric cancer: a propensity score-matching analysis. J Cancer Res Clin Oncol 2021;147:2385-96. [PMID: 33534051 DOI: 10.1007/s00432-021-03516-7] [Reference Citation Analysis]
69 Nelson R, Ko EB, Arrington A, Lee W, Kim J, Garcia-Aguilar J, Kim J. Race and correlations between lymph node number and survival for patients with gastric cancer. J Gastrointest Surg. 2013;17:471-481. [PMID: 23288716 DOI: 10.1007/s11605-012-2125-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
70 Zhou D, Wu Y, Lin Z, Shi L, Zhao L, Liu T, Yu D, Zhang T. Prognostic Value of Combination of Pretreatment Red Cell Distribution Width and Neutrophil-to-Lymphocyte Ratio in Patients with Gastric Cancer. Gastroenterol Res Pract 2018;2018:8042838. [PMID: 29643918 DOI: 10.1155/2018/8042838] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
71 Yamaguchi K, Yoshida K, Tanahashi T, Takahashi T, Matsuhashi N, Tanaka Y, Tanabe K, Ohdan H. The long-term survival of stage IV gastric cancer patients with conversion therapy. Gastric Cancer 2018;21:315-23. [PMID: 28616743 DOI: 10.1007/s10120-017-0738-1] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 7.8] [Reference Citation Analysis]
72 Qiu HB, Zhang LY, Ren C, Zeng ZL, Wu WJ, Luo HY, Zhou ZW, Xu RH. Targeting CDH17 suppresses tumor progression in gastric cancer by downregulating Wnt/β-catenin signaling. PLoS One. 2013;8:e56959. [PMID: 23554857 DOI: 10.1371/journal.pone.0056959] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
73 Mengardo V, Bencivenga M, Weindelmayer J, Pavarana M, Giacopuzzi S, de Manzoni G. Para-aortic lymphadenectomy in surgery for gastric cancer: current indications and future perspectives. Updates Surg 2018;70:207-11. [PMID: 29846892 DOI: 10.1007/s13304-018-0549-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
74 Park SR, Kang Y. Perioperative treatments for resectable gastric cancer. J Korean Med Assoc 2015;58:201. [DOI: 10.5124/jkma.2015.58.3.201] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
75 Knab LM, Yang A. Gastric and Small Bowel Tumors. Cancer Treat Res 2016;168:1-16. [PMID: 29206015 DOI: 10.1007/978-3-319-34244-3_1] [Reference Citation Analysis]
76 Shen ZL, Song KY, Ye YJ, Xie QW, Liang B, Jiang K, Park CH, Wang S. Significant differences in the clinicopathological characteristics and survival of gastric cancer patients from two cancer centers in china and Korea. J Gastric Cancer. 2015;15:19-28. [PMID: 25861519 DOI: 10.5230/jgc.2015.15.1.19] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
77 Wang FH, Zhang XT, Li YF, Tang L, Qu XJ, Ying JE, Zhang J, Sun LY, Lin RB, Qiu H, Wang C, Qiu MZ, Cai MY, Wu Q, Liu H, Guan WL, Zhou AP, Zhang YJ, Liu TS, Bi F, Yuan XL, Rao SX, Xin Y, Sheng WQ, Xu HM, Li GX, Ji JF, Zhou ZW, Liang H, Zhang YQ, Jin J, Shen L, Li J, Xu RH. The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021. Cancer Commun (Lond) 2021;41:747-95. [PMID: 34197702 DOI: 10.1002/cac2.12193] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
78 Grasso M, Pacella G, Sangiuliano N, De Palma M, Puzziello A. Gastric cancer surgery: clinical outcomes and prognosis are influenced by perioperative blood transfusions. Updates Surg 2019;71:439-43. [PMID: 30659478 DOI: 10.1007/s13304-019-00622-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
79 Li H, Chen XL, Li JR, Li ZL, Chen TW, Pu H, Yin LL, Xu GH, Li ZW, Reng J, Zhou P, Cheng ZZ, Cao Y. Tumor volume of resectable gastric adenocarcinoma on multidetector computed tomography: association with N categories. Clinics (Sao Paulo) 2016;71:199-204. [PMID: 27166769 DOI: 10.6061/clinics/2016(04)04] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
80 Yazawa T, Hori T, Yamamoto H, Harada H, Yamamoto M, Yamada M, Tani M, Sato A, Kamada Y, Tani R, Aoyama R, Sasaki Y, Zaima M. Do liver metastases from gastric cancer contraindicate aggressive surgical resection? A 14-year single-center experience. World J Gastrointest Pharmacol Ther 2020; 11(5): 110-122 [PMID: 33251035 DOI: 10.4292/wjgpt.v11.i5.110] [Reference Citation Analysis]
81 Yang K, Chen HN, Liu K, Zhang WH, Chen XZ, Chen XL, Zhou ZG, Hu JK. The survival benefit and safety of No. 12a lymphadenectomy for gastric cancer patients with distal or total gastrectomy. Oncotarget 2016;7:18750-62. [PMID: 26959745 DOI: 10.18632/oncotarget.7930] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
82 Quadri HS, Smaglo BG, Morales SJ, Phillips AC, Martin AD, Chalhoub WM, Haddad NG, Unger KR, Levy AD, Al-Refaie WB. Gastric Adenocarcinoma: A Multimodal Approach.Front Surg. 2017;4:42. [PMID: 28824918 DOI: 10.3389/fsurg.2017.00042] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
83 Kumagai K, Yamamoto N, Miyashiro I, Tomita Y, Katai H, Kushima R, Tsuda H, Kitagawa Y, Takeuchi H, Mukai M, Mano M, Mochizuki H, Kato Y, Matsuura N, Sano T. Multicenter study evaluating the clinical performance of the OSNA assay for the molecular detection of lymph node metastases in gastric cancer patients. Gastric Cancer 2014;17:273-80. [PMID: 23743877 DOI: 10.1007/s10120-013-0271-9] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 5.4] [Reference Citation Analysis]
84 Guo DJ, Yang K, Zhang WH, Chen XL, Chen XZ, Zhang B, Zhou ZG, Hu JK. Prognostic Value of Metastatic No.8p LNs in Patients with Gastric Cancer. Gastroenterol Res Pract 2015;2015:937682. [PMID: 26649037 DOI: 10.1155/2015/937682] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
85 Kawamura Y, Satoh S, Suda K, Ishida Y, Kanaya S, Uyama I. Critical factors that influence the early outcome of laparoscopic total gastrectomy. Gastric Cancer. 2015;18:662-668. [PMID: 24906557 DOI: 10.1007/s10120-014-0392-9] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
86 Kinoshita J, Yamaguchi T, Moriyama H, Fushida S. Current status of conversion surgery for stage IV gastric cancer. Surg Today 2021. [PMID: 33486610 DOI: 10.1007/s00595-020-02222-0] [Reference Citation Analysis]
87 Cravo M, Fidalgo C, Garrido R, Rodrigues T, Luz G, Palmela C, Santos M, Lopes F, Maio R. Towards curative therapy in gastric cancer: Faraway, so close!. World J Gastroenterol 2015; 21(41): 11609-11620 [PMID: 26556990 DOI: 10.3748/wjg.v21.i41.11609] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
88 Sah BK, Chen MM, Yan M, Zhu ZG. Reoperation for early postoperative complications after gastric cancer surgery in a Chinese hospital. World J Gastroenterol 2010; 16(1): 98-103 [PMID: 20039455 DOI: 10.3748/wjg.v16.i1.98] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
89 Katai H, Ishikawa T, Akazawa K, Isobe Y, Miyashiro I, Oda I, Tsujitani S, Ono H, Tanabe S, Fukagawa T, Nunobe S, Kakeji Y, Nashimoto A;  Registration Committee of the Japanese Gastric Cancer Association. Five-year survival analysis of surgically resected gastric cancer cases in Japan: a retrospective analysis of more than 100,000 patients from the nationwide registry of the Japanese Gastric Cancer Association (2001-2007). Gastric Cancer. 2018;21:144-154. [PMID: 28417260 DOI: 10.1007/s10120-017-0716-7] [Cited by in Crossref: 133] [Cited by in F6Publishing: 115] [Article Influence: 26.6] [Reference Citation Analysis]
90 Yagi S, Yamada K, Terayama M, Wake H, Enomoto N, Nohara K, Takemura N, Kiyomatsu T, Kokudo N. Current status of doublet combinations of platinum and fluoropyrimidines using oxaliplatin for advanced gastric cancer. Glob Health Med 2021;3:31-6. [PMID: 33688593 DOI: 10.35772/ghm.2020.01075] [Reference Citation Analysis]
91 Abdi H, Pourmalek F, Gleave ME, So AI, Black PC. Balancing risk and benefit of extended pelvic lymph node dissection in patients undergoing radical cystectomy. World J Urol 2016;34:41-8. [PMID: 26621208 DOI: 10.1007/s00345-015-1734-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
92 Wang X, Jin J, Li YX, Ren H, Fang H, Wang SL, Liu YP, Wang WH, Yu ZH, Song YW, Liu XF. Phase I study of postoperative radiotherapy combined with capecitabine for gastric cancer. World J Gastroenterol 2014; 20(4): 1067-1073 [PMID: 24574780 DOI: 10.3748/wjg.v20.i4.1067] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
93 Gao J, Gao P. Importance of No. 8 lymph node dissection in standard D2 radical gastrectomy for gastric cancer. Shijie Huaren Xiaohua Zazhi 2019; 27(21): 1326-1329 [DOI: 10.11569/wcjd.v27.i21.1326] [Reference Citation Analysis]
94 Tani R, Hori T, Yamamoto H, Harada H, Yamamoto M, Yamada M, Yazawa T, Sasaki B, Tani M, Sato A, Katsura H, Kamada Y, Aoyama R, Sasaki Y, Zaima M. Aggressive Resection of Malignant Paraaortic and Pelvic Tumors Accompanied by Arterial Reconstruction with Synthetic Arterial Graft. Am J Case Rep 2021;22:e931569. [PMID: 33931576 DOI: 10.12659/AJCR.931569] [Reference Citation Analysis]
95 Hu JK, Yang K, Zhang B, Chen XZ, Chen ZX, Chen JP. D2 plus para-aortic lymphadenectomy versus standardized D2 lymphadenectomy in gastric cancer surgery. Surg Today. 2009;39:207-213. [PMID: 19280279 DOI: 10.1007/s00595-008-3856-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
96 Antonakis PT, Ashrafian H, Isla AM. Laparoscopic gastric surgery for cancer: Where do we stand? World J Gastroenterol 2014; 20(39): 14280-14291 [PMID: 25339815 DOI: 10.3748/wjg.v20.i39.14280] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
97 Saijo N. Highlights for ESMO 40: celebration review for lifetime achievement awards. ESMO Open 2016;1:e000010. [PMID: 27843584 DOI: 10.1136/esmoopen-2015-000010] [Reference Citation Analysis]
98 Xie D, Yu C, Liu L, Osaiweran H, Gao C, Hu J, Gong J. Short-term outcomes of laparoscopic D2 lymphadenectomy with complete mesogastrium excision for advanced gastric cancer. Surg Endosc 2016;30:5138-9. [PMID: 27005289 DOI: 10.1007/s00464-016-4847-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
99 Li Z, Ao S, Bu Z, Wu A, Wu X, Shan F, Ji X, Zhang Y, Xing Z, Ji J. Clinical study of harvesting lymph nodes with carbon nanoparticles in advanced gastric cancer: a prospective randomized trial. World J Surg Oncol 2016;14:88. [PMID: 27009101 DOI: 10.1186/s12957-016-0835-3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
100 Ojima T, Iwahashi M, Nakamori M, Nakamura M, Takifuji K, Katsuda M, Iida T, Tsuji T, Hayata K, Yamaue H. The impact of abdominal shape index of patients on laparoscopy-assisted distal gastrectomy for early gastric cancer. Langenbecks Arch Surg 2012;397:437-45. [PMID: 22134749 DOI: 10.1007/s00423-011-0883-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
101 Guo J, Xu A, Sun X, Zhao X, Xia Y, Rao H, Zhang Y, Zhang R, Chen L, Zhang T, Li G, Xu H, Xu D. Three-year outcomes of the randomized phase III SEIPLUS trial of extensive intraoperative peritoneal lavage for locally advanced gastric cancer. Nat Commun 2021;12:6598. [PMID: 34782599 DOI: 10.1038/s41467-021-26778-8] [Reference Citation Analysis]
102 Park JH, Lee HJ, Oh SY, Park SH, Berlth F, Son YG, Kim TH, Huh YJ, Yang JY, Lee KG, Suh YS, Kong SH, Yang HK. Prediction of Postoperative Mortality in Patients with Organ Failure After Gastric Cancer Surgery. World J Surg 2020;44:1569-77. [PMID: 31993720 DOI: 10.1007/s00268-020-05382-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
103 Małczak P, Torbicz G, Rubinkiewicz M, Gajewska N, Sajuk N, Rozmus K, Wysocki M, Major P, Budzyński A, Pędziwiatr M. Comparison of totally laparoscopic and open approach in total gastrectomy with D2 lymphadenectomy - systematic review and meta-analysis. Cancer Manag Res 2018;10:6705-14. [PMID: 30584365 DOI: 10.2147/CMAR.S182557] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
104 Yoshida K, Yasufuku I, Terashima M, Young Rha S, Moon Bae J, Li G, Katai H, Watanabe M, Seto Y, Hoon Noh S, Kwang Yang H, Ji J, Baba H, Kitagawa Y, Morita S, Nishiyama M, Kodera Y; CONVO‐GC‐1 Study Group, Federation of Asian Clinical Oncology (FACO). International Retrospective Cohort Study of Conversion Therapy for Stage IV Gastric Cancer 1 (CONVO‐GC‐1). Ann Gastroenterol Surg. [DOI: 10.1002/ags3.12515] [Reference Citation Analysis]
105 Tokuhara T, Tanigawa N, Matsuki M, Nomura E, Mabuchi H, Lee SW, Tatsumi Y, Nishimura H, Yoshinaka R, Kurisu Y, Narabayashi I. Evaluation of lymph node metastases in gastric cancer using magnetic resonance imaging with ultrasmall superparamagnetic iron oxide (USPIO): diagnostic performance in post-contrast images using new diagnostic criteria. Gastric Cancer 2008;11:194-200. [PMID: 19132480 DOI: 10.1007/s10120-008-0480-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
106 Hanisch E. Preventing and managing complications of laparoscopic gastrectomy. Surg Endosc 2009;23:2855-7. [PMID: 19551435 DOI: 10.1007/s00464-009-0581-5] [Reference Citation Analysis]
107 Sammartino P, Biacchi D, Cornali T, Cardi M, Accarpio F, Impagnatiello A, Sollazzo BM, Di Giorgio A. Proactive Management for Gastric, Colorectal and Appendiceal Malignancies: Preventing Peritoneal Metastases with Hyperthermic Intraperitoneal Chemotherapy (HIPEC). Indian J Surg Oncol 2016;7:215-24. [PMID: 27065712 DOI: 10.1007/s13193-016-0497-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
108 Wang Z, Chen JQ, Cao YF. Systematic review of D2 lymphadenectomy versus D2 with para-aortic nodal dissection for advanced gastric cancer. World J Gastroenterol 2010; 16(9): 1138-1149 [PMID: 20205287 DOI: 10.3748/wjg.v16.i9.1138] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
109 Peixoto RD, Rocha-Filho DR, Weschenfelder RF, Rego JFM, Riechelmann R, Coutinho AK, Fernandes GS, Jacome AA, Andrade AC, Murad AM, Mello CAL, Miguel DSCG, Gomes DBD, Racy DJ, Moraes ED, Akaishi EH, Carvalho ES, Mello ES, Filho FM, Coimbra FJF, Capareli FC, Arruda FF, Vieira FMAC, Takeda FR, Cotti GCC, Pereira GLS, Paulo GA, Ribeiro HSC, Lourenco LG, Crosara M, Toneto MG, Oliveira MB, de Lourdes Oliveira M, Begnami MD, Forones NM, Yagi O, Ashton-Prolla P, Aguillar PB, Amaral PCG, Hoff PM, Araujo RLC, Filho RPDP, Gansl RC, Gil RA, Pfiffer TEF, Souza T, Jr UR, Jesus VHF, Jr WLC, Prolla G. Brazilian Group of Gastrointestinal Tumours' consensus guidelines for the management of gastric cancer. Ecancermedicalscience 2020;14:1126. [PMID: 33209117 DOI: 10.3332/ecancer.2020.1126] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
110 Terashima M. The 140 years' journey of gastric cancer surgery: From the two hands of Billroth to the multiple hands of the robot. Ann Gastroenterol Surg 2021;5:270-7. [PMID: 34095716 DOI: 10.1002/ags3.12442] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
111 Shinohara S, Korenaga D, Edagawa A, Koushi K, Itoh S, Kawanaka H, Eguchi D, Kawasaki K, Okuyama T, Ikeda Y, Takenaka K. Significant prognostic factors in patients with Stage IV gastric cancer with special reference to the curability of surgery. Surg Today 2013;43:40-7. [PMID: 22743702 DOI: 10.1007/s00595-012-0230-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
112 Aoyama T, Yoshikawa T, Watanabe T, Hayashi T, Ogata T, Cho H, Tsuburaya A. Safety and feasibility of S-1 adjuvant chemotherapy for gastric cancer in elderly patients. Gastric Cancer 2012;15:76-82. [PMID: 21717091 DOI: 10.1007/s10120-011-0068-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
113 Ohashi M, Morita S, Fukagawa T, Wada T, Kushima R, Onaya H, Katai H. Evaluation of 64-Channel Contrast-Enhanced Multi-detector Row Computed Tomography for Preoperative N Staging in cT2-4 Gastric Carcinoma. World J Surg. 2016;40:165-171. [PMID: 26552913 DOI: 10.1007/s00268-015-3318-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
114 Goltzman ME, Gogoj A, Ristau BT. The role of lymphadenectomy at the time of radical nephroureterectomy for upper tract urothelial carcinoma. Transl Androl Urol 2020;9:1860-7. [PMID: 32944550 DOI: 10.21037/tau.2019.11.29] [Reference Citation Analysis]
115 Oh HS, Eom DW, Kang GH, Ahn YC, Lee SJ, Kim JH, Jang HJ, Kim EJ, Oh KH, Ahn HJ. Prognostic implications of EGFR and HER-2 alteration assessed by immunohistochemistry and silver in situ hybridization in gastric cancer patients following curative resection. Gastric Cancer. 2014;17:402-411. [PMID: 23955257 DOI: 10.1007/s10120-013-0288-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
116 Zurleni T, Gjoni E, Altomare M, Rausei S. Conversion surgery for gastric cancer patients: A review. World J Gastrointest Oncol 2018; 10(11): 398-409 [PMID: 30487951 DOI: 10.4251/wjgo.v10.i11.398] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
117 Kubota T, Shoda K, Konishi H, Okamoto K, Otsuji E. Nutrition update in gastric cancer surgery. Ann Gastroenterol Surg 2020;4:360-8. [PMID: 32724879 DOI: 10.1002/ags3.12351] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
118 An JY, Cheong JH, Hyung WJ, Noh SH. Recent evolution of surgical treatment for gastric cancer in Korea. J Gastric Cancer. 2011;11:1-6. [PMID: 22076195 DOI: 10.5230/jgc.2011.11.1.1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
119 Etoh T, Shiroshita H, Shiraishi N, Kitano S, Inomata M. Ongoing clinical studies of minimally invasive surgery for gastric cancer in Japan. Transl Gastroenterol Hepatol 2016;1:31. [PMID: 28138598 DOI: 10.21037/tgh.2016.03.15] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
120 Özer İ, Bostancı EB, Ulaş M, Özoğul Y, Akoğlu M. Changing Trends in Gastric Cancer Surgery. Balkan Med J 2017;34:10-20. [PMID: 28251018 DOI: 10.4274/balkanmedj.2015.1461] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
121 Sano T, Aiko T. New Japanese classifications and treatment guidelines for gastric cancer: revision concepts and major revised points. Gastric Cancer. 2011;14:97-100. [PMID: 21573921 DOI: 10.1007/s10120-011-0040-6] [Cited by in Crossref: 189] [Cited by in F6Publishing: 171] [Article Influence: 17.2] [Reference Citation Analysis]
122 Kawamura Y, Satoh S, Umeki Y, Ishida Y, Suda K, Uyama I. Evaluation of the recurrence pattern of gastric cancer after laparoscopic gastrectomy with D2 lymphadenectomy. Springerplus 2016;5:821. [PMID: 27390661 DOI: 10.1186/s40064-016-2535-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
123 Zheng ZF, Lu J, Xie JW, Wang JB, Lin JX, Chen QY, Cao LL, Lin M, Tu RH, Zheng CH, Huang CM, Li P. Preoperative skeletal muscle index vs the controlling nutritional status score: Which is a better objective predictor of long-term survival for gastric cancer patients after radical gastrectomy? Cancer Med 2018;7:3537-47. [PMID: 29953752 DOI: 10.1002/cam4.1548] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
124 Kandil MS, Bazarbashi SN, Rahal MM, Al-Shehri AS, Alzahrani AM, Aljubran AH, Zekri JE, Al Olayan AA, Alsharm AA, Yamani NM, Alomary IS, Fagih MA; Saudi Oncology Society. Saudi Oncology Society clinical management guideline series. Gastric cancer 2014. Saudi Med J 2014;35:1529-33. [PMID: 25491224] [Reference Citation Analysis]
125 Kanaji S, Suzuki S, Matsuda Y, Hasegawa H, Yamamoto M, Yamashita K, Oshikiri T, Matsuda T, Nakamura T, Sumi Y, Kakeji Y. Recent updates in perioperative chemotherapy and recurrence pattern of gastric cancer. Ann Gastroenterol Surg. 2018;2:400-405. [PMID: 30460342 DOI: 10.1002/ags3.12199] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
126 Kosuga T, Ichikawa D, Okamoto K, Komatsu S, Shiozaki A, Fujiwara H, Otsuji E. Survival benefits from splenic hilar lymph node dissection by splenectomy in gastric cancer patients: relative comparison of the benefits in subgroups of patients. Gastric Cancer. 2011;14:172-177. [PMID: 21331530 DOI: 10.1007/s10120-011-0028-2] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 4.0] [Reference Citation Analysis]
127 Kim CY, Nam BH, Cho GS, Hyung WJ, Kim MC, Lee HJ, Ryu KW, Ryu SW, Shin DW, Lee JH. Learning curve for gastric cancer surgery based on actual survival. Gastric Cancer 2016;19:631-8. [PMID: 25711979 DOI: 10.1007/s10120-015-0477-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.9] [Reference Citation Analysis]
128 Kurokawa Y, Yamaguchi T, Sasako M, Sano T, Mizusawa J, Nakamura K, Fukuda H. Institutional variation in short- and long-term outcomes after surgery for gastric or esophagogastric junction adenocarcinoma: correlative study of two randomized phase III trials (JCOG9501 and JCOG9502). Gastric Cancer 2017;20:508-16. [PMID: 27568321 DOI: 10.1007/s10120-016-0636-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
129 Lin JX, Huang CM, Zheng CH, Li P, Xie JW, Wang JB, and Lu J, Laparoscopy-assisted gastrectomy with D2 lymph node dissection for advanced gastric cancer without serosa invasion: a matched cohort study from South China World J Surg Oncol. 2013;11:4. [PMID: 23311966 DOI: 10.1186/1477-7819-11-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
130 Iyer P, Moslim M, Farma JM, Denlinger CS. Diffuse gastric cancer: histologic, molecular, and genetic basis of disease. Transl Gastroenterol Hepatol 2020;5:52. [PMID: 33073047 DOI: 10.21037/tgh.2020.01.02] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
131 Lee TY, Liao GS, Fan HL, Hsieh CB, Chen TW, Chan DC. Conversion Surgery for Patients with Advanced Gastric Cancer with Peritoneal Carcinomatosis. J Oncol 2021;2021:5459432. [PMID: 34804160 DOI: 10.1155/2021/5459432] [Reference Citation Analysis]
132 Fuchs CS, Niedzwiecki D, Mamon HJ, Tepper JE, Ye X, Swanson RS, Enzinger PC, Haller DG, Dragovich T, Alberts SR, Bjarnason GA, Willett CG, Gunderson LL, Goldberg RM, Venook AP, Ilson D, O'Reilly E, Ciombor K, Berg DJ, Meyerhardt J, Mayer RJ. Adjuvant Chemoradiotherapy With Epirubicin, Cisplatin, and Fluorouracil Compared With Adjuvant Chemoradiotherapy With Fluorouracil and Leucovorin After Curative Resection of Gastric Cancer: Results From CALGB 80101 (Alliance). J Clin Oncol. 2017;35:3671-3677. [PMID: 28976791 DOI: 10.1200/jco.2017.74.2130] [Cited by in Crossref: 62] [Cited by in F6Publishing: 21] [Article Influence: 12.4] [Reference Citation Analysis]
133 Kurokawa Y, Sasako M, Sano T, Yoshikawa T, Iwasaki Y, Nashimoto A, Ito S, Kurita A, Mizusawa J, Nakamura K; Japan Clinical Oncology Group (JCOG9502). Ten-year follow-up results of a randomized clinical trial comparing left thoracoabdominal and abdominal transhiatal approaches to total gastrectomy for adenocarcinoma of the oesophagogastric junction or gastric cardia. Br J Surg. 2015;102:341-348. [PMID: 25605628 DOI: 10.1002/bjs.9764] [Cited by in Crossref: 56] [Cited by in F6Publishing: 47] [Article Influence: 8.0] [Reference Citation Analysis]
134 Guan G, Jiang W, Chen Z, Liu X, Lu H, Zhang X. Early results of a modified splenic hilar lymphadenectomy in laparoscopy-assisted total gastrectomy for gastric cancer with stage cT1-2: a case–control study. Surg Endosc 2013;27:1923-31. [DOI: 10.1007/s00464-012-2688-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
135 Sawaki A, Ohashi Y, Omuro Y, Satoh T, Hamamoto Y, Boku N, Miyata Y, Takiuchi H, Yamaguchi K, Sasaki Y, Nishina T, Satoh A, Baba E, Tamura T, Abe T, Hatake K, Ohtsu A. Efficacy of trastuzumab in Japanese patients with HER2-positive advanced gastric or gastroesophageal junction cancer: a subgroup analysis of the Trastuzumab for Gastric Cancer (ToGA) study. Gastric Cancer 2012;15:313-22. [PMID: 22179434 DOI: 10.1007/s10120-011-0118-1] [Cited by in Crossref: 61] [Cited by in F6Publishing: 60] [Article Influence: 5.5] [Reference Citation Analysis]
136 Tokunaga M, Makuuchi R, Miki Y, Tanizawa Y, Bando E, Kawamura T, Terashima M. Surgical and Survival Outcome Following Truly Palliative Gastrectomy in Patients with Incurable Gastric Cancer. World J Surg 2016;40:1172-7. [PMID: 26754075 DOI: 10.1007/s00268-015-3398-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
137 Jung MR, Park YK, Seon JW, Kim KY, Cheong O, Ryu SY. Definition and classification of complications of gastrectomy for gastric cancer based on the accordion severity grading system. World J Surg. 2012;36:2400-2411. [PMID: 22752074 DOI: 10.1007/s00268-012-1693-y] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 4.1] [Reference Citation Analysis]
138 Matsui K, Sakuramoto S, Sugita H, Nishibeppu K, Ebara G, Fujita S, Fujihata S, Oya S, Miyawaki Y, Sato H, Yamashita K. Short- and long-term outcomes of laparoscopic distal gastrectomy versus open distal gastrectomy for gastric cancer in overweight patients. Surg Today. [DOI: 10.1007/s00595-022-02455-1] [Reference Citation Analysis]
139 Tóth D, Plósz J, Török M. Clinical significance of lymphadenectomy in patients with gastric cancer. World J Gastrointest Oncol 2016; 8(2): 136-146 [PMID: 26909128 DOI: 10.4251/wjgo.v8.i2.136] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
140 Deng J, Liu J, Wang W, Sun Z, Wang Z, Zhou Z, Xu H, Liang H. Validation of clinical significance of examined lymph node count for accurate prognostic evaluation of gastric cancer for the eighth edition of the American Joint Committee on Cancer (AJCC) TNM staging system. Chin J Cancer Res 2018;30:477-91. [PMID: 30510359 DOI: 10.21147/j.issn.1000-9604.2018.05.01] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
141 Liao G, Chen J, Ren C, Li R, Du S, Xie G, Deng H, Yang K, Yuan Y. Robotic versus open gastrectomy for gastric cancer: a meta-analysis. PLoS One 2013;8:e81946. [PMID: 24312610 DOI: 10.1371/journal.pone.0081946] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 3.7] [Reference Citation Analysis]
142 Chen QY, Hong ZL, Zhong Q, Liu ZY, Huang XB, Que SJ, Li P, Xie JW, Wang JB, Lin JX, Lu J, Cao LL, Lin M, Tu RH, Zheng CH, Huang CM. Nomograms for pre- and postoperative prediction of long-term survival among proximal gastric cancer patients: A large-scale, single-center retrospective study. World J Clin Cases 2019; 7(21): 3419-3435 [PMID: 31750326 DOI: 10.12998/wjcc.v7.i21.3419] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
143 Hioki M, Gotohda N, Konishi M, Nakagohri T, Takahashi S, Kinoshita T. Predictive factors improving survival after gastrectomy in gastric cancer patients with peritoneal carcinomatosis. World J Surg. 2010;34:555-562. [PMID: 20082194 DOI: 10.1007/s00268-010-0396-5] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 2.9] [Reference Citation Analysis]
144 Zhu H, Zhang MY, Sun WL, Chen G. Mixed neuroendocrine carcinoma of the gastric stump: A case report. World J Clin Cases 2021; 9(27): 8090-8096 [PMID: 34621866 DOI: 10.12998/wjcc.v9.i27.8090] [Reference Citation Analysis]
145 Santoro R, Ettorre GM, Santoro E. Subtotal gastrectomy for gastric cancer. World J Gastroenterol 2014; 20(38): 13667-13680 [PMID: 25320505 DOI: 10.3748/wjg.v20.i38.13667] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
146 Kinami S, Saito H, Takamura H. Significance of Lymph Node Metastasis in the Treatment of Gastric Cancer and Current Challenges in Determining the Extent of Metastasis. Front Oncol 2021;11:806162. [PMID: 35071010 DOI: 10.3389/fonc.2021.806162] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
147 Fugazzola P, Ansaloni L, Sartelli M, Catena F, Cicuttin E, Leandro G, De' Angelis GL, Gaiani F, Di Mario F, Tomasoni M, Coccolini F. Advanced gastric cancer: the value of surgery. Acta Biomed 2018;89:110-6. [PMID: 30561428 DOI: 10.23750/abm.v89i8-S.7897] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
148 Iwasa S, Yamada Y, Fukagawa T, Eguchi Nakajima T, Kato K, Hamaguchi T, Morita S, Saka M, Katai H, Shimada Y. Management of adjuvant S-1 therapy after curative resection of gastric cancer: dose reduction and treatment schedule modification. Gastric Cancer 2011;14:28-34. [PMID: 21327440 DOI: 10.1007/s10120-011-0003-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
149 Zhang YX, Yang K. Significance of nodal dissection and nodal positivity in gastric cancer. Transl Gastroenterol Hepatol 2020;5:17. [PMID: 32258521 DOI: 10.21037/tgh.2019.09.13] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
150 Lin JP, Lin JX, Cao LL, Zheng CH, Li P, Xie JW, Wang JB, Lu J, Chen QY, Lin M, Tu RH, Huang CM. Preoperative lymphocyte-to-monocyte ratio as a strong predictor of survival and recurrence for gastric cancer after radical-intent surgery. Oncotarget 2017;8:79234-47. [PMID: 29108302 DOI: 10.18632/oncotarget.17058] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
151 Mrena J, Mattila A, Böhm J, Jantunen I, Kellokumpu I. Surgical care quality and oncologic outcome after D2 gastrectomy for gastric cancer. World J Gastroenterol 2015; 21(47): 13294-13301 [PMID: 26715812 DOI: 10.3748/wjg.v21.i47.13294] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
152 Hottenrott C. Body mass index and risks of laparoscopic gastrectomy. Surg Endosc 2009;23:2864-6. [PMID: 19484307 DOI: 10.1007/s00464-009-0523-2] [Reference Citation Analysis]
153 Marrelli D, De Franco L, Iudici L, Polom K, Roviello F. Lymphadenectomy: state of the art. Transl Gastroenterol Hepatol 2017;2:3. [PMID: 28217753 DOI: 10.21037/tgh.2017.01.01] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
154 Son SY, Lee CM, Lee JH, Ahn SH, Kim JW, Lee KU, Park do J, Kim HH. Laparoscopy-assisted gastrectomy with para-aortic lymphadenectomy after palliative chemotherapy for advanced gastric cancer with isolated para-aortic lymph node metastasis. J Korean Surg Soc. 2013;84:304-308. [PMID: 23646317 DOI: 10.4174/jkss.2013.84.5.304] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
155 Hartgrink HH. Improving outcome for scirrhous gastric cancer. Gastric Cancer 2009;12:3-5. [PMID: 19390926 DOI: 10.1007/s10120-009-0501-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
156 Matsuda T, Kurokawa Y, Yoshikawa T, Kishi K, Misawa K, Ohi M, Mine S, Hiki N, Takeuchi H. Clinicopathological Characteristics and Prognostic Factors of Patients with Siewert Type II Esophagogastric Junction Carcinoma: A Retrospective Multicenter Study. World J Surg 2016;40:1672-9. [PMID: 26928855 DOI: 10.1007/s00268-016-3451-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
157 Chalkiadakis GE, Ziogas D. Progress and limitations of surgery in improving outcomes of esophagogastric junction cancer. Ann Surg Oncol 2009;16:2074-5; author reply 2076. [PMID: 19365623 DOI: 10.1245/s10434-009-0461-1] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
158 Katsios C, Roukos DH, Baltogiannis G. Hope from Japan for esophagogastric cancers: esophagectomy and endoscopic submucosal dissection for gastric tube cancer. Surg Endosc 2010;24:2924-5. [PMID: 20354872 DOI: 10.1007/s00464-010-1024-z] [Reference Citation Analysis]
159 Gong Y, Wang P, Zhu Z, Zhang J, Huang J, Xu H. Clinicopathological Characteristics and Prognosis of Upper Gastric Cancer Patients in China: A 32-Year Single-Center Retrospective Clinical Study. Gastroenterol Res Pract 2019;2019:9248394. [PMID: 31885548 DOI: 10.1155/2019/9248394] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
160 Girnyi S, Ekman M, Marano L, Roviello F, Połom K. Complete Mesogastric Excisions Involving Anatomically Based Concepts and Embryological-Based Surgeries: Current Knowledge and Future Challenges. Curr Oncol 2021;28:4929-37. [PMID: 34898586 DOI: 10.3390/curroncol28060413] [Reference Citation Analysis]
161 Zhang H, Liu C, Wu D, Meng Y, Song R, Lu P, Wang S. Does D3 surgery offer a better survival outcome compared to D1 surgery for gastric cancer A result based on a hospital population of two decades as taking D2 surgery for reference. BMC Cancer. 2010;10:308. [PMID: 20565910 DOI: 10.1186/1471-2407-10-308] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
162 Miceli R, Tomasello G, Bregni G, Bartolomeo MD, Pietrantonio F. Adjuvant chemotherapy for gastric cancer: Current evidence and future challenges. World J Gastroenterol 2014; 20(16): 4516-4525 [PMID: 24782604 DOI: 10.3748/wjg.v20.i16.4516] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
163 Yamashita K, Sakuramoto S, Watanabe M. Genomic and epigenetic profiles of gastric cancer: Potential diagnostic and therapeutic applications. Surg Today 2011;41:24-38. [DOI: 10.1007/s00595-010-4370-5] [Cited by in Crossref: 61] [Cited by in F6Publishing: 64] [Article Influence: 5.1] [Reference Citation Analysis]
164 Kim HJ, Kang TW, Haam K, Kim M, Kim SK, Kim SY, Lee SI, Song KS, Jeong HY, Kim YS. Whole genome MBD-seq and RRBS analyses reveal that hypermethylation of gastrointestinal hormone receptors is associated with gastric carcinogenesis. Exp Mol Med. 2018;50:156. [PMID: 30510283 DOI: 10.1038/s12276-018-0179-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
165 Hottenrott C. The long-term efficacy of laparoscopic surgery in early and advanced gastric cancer. Surg Endosc. 2012;26:3695-3696. [PMID: 22538683 DOI: 10.1007/s00464-012-2275-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
166 Sasaki K, Onodera S, Otsuka K, Satomura H, Kurayama E, Kubo T, Takahashi M, Ito J, Nakajima M, Yamaguchi S, Miyachi K, Kato H. Validity of neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1 for resectable locally advanced gastric cancer. Med Oncol 2017;34:139. [PMID: 28707042 DOI: 10.1007/s12032-017-0997-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
167 Chen J, Bu Z, Ji J. Surgical treatment of gastric cancer: Current status and future directions. Chin J Cancer Res 2021;33:159-67. [PMID: 34158736 DOI: 10.21147/j.issn.1000-9604.2021.02.04] [Reference Citation Analysis]
168 Deng J, Liang H, Wang D, Sun D, Pan Y, Liu Y. Investigation of the recurrence patterns of gastric cancer following a curative resection. Surg Today. 2011;41:210-215. [PMID: 21264756 DOI: 10.1007/s00595-009-4251-y] [Cited by in Crossref: 58] [Cited by in F6Publishing: 60] [Article Influence: 5.3] [Reference Citation Analysis]
169 Kakeji Y, Morita M, Maehara Y. Strategies for treating liver metastasis from gastric cancer. Surg Today. 2010;40:287-294. [PMID: 20339981 DOI: 10.1007/s00595-009-4152-0] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
170 Lin JX, Lin JP, Xie JW, Wang JB, Lu J, Chen QY, Cao LL, Lin M, Tu R, Zheng CH, Huang CM, Li P. Complete blood count-based inflammatory score (CBCS) is a novel prognostic marker for gastric cancer patients after curative resection. BMC Cancer 2020;20:11. [PMID: 31906893 DOI: 10.1186/s12885-019-6466-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
171 Tian YL, Cao SG, Liu XD, Li ZQ, Liu G, Zhang XQ, Sun YQ, Zhou X, Wang DS, Zhou YB. Short- and long-term outcomes associated with enhanced recovery after surgery protocol vs conventional management in patients undergoing laparoscopic gastrectomy. World J Gastroenterol 2020; 26(37): 5646-5660 [PMID: 33088158 DOI: 10.3748/wjg.v26.i37.5646] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
172 Hölscher AH, Fetzner UK. [Modern diagnostics and stage-oriented surgery: therapy of adenocarcinoma of the esophagogastric junction]. Chirurg 2012;83:702-8, 710-1. [PMID: 22878576 DOI: 10.1007/s00104-011-2264-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
173 Rausei S, Dionigi G, Rovera F, Boni L, Valerii C, Giavarini L, Frattini F, Dionigi R. A decade in gastric cancer curative surgery: Evidence of progress (1999-2009). World J Gastrointest Surg 2012; 4(3): 45-54 [PMID: 22530078 DOI: 10.4240/wjgs.v4.i3.45] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
174 Panin SI, Postolov MP, Kovalenko NV, Beburishvili AG, Fedorov AV, Bykov AV. [Distal subtotal gastrectomy and gastreectomy in surgical treatment of patients with gastric cancer: a systematic review and meta-analysis]. Khirurgiia (Mosk) 2020;:93-100. [PMID: 33210514 DOI: 10.17116/hirurgia202011193] [Reference Citation Analysis]
175 Kitano T, Aisu Y, Yasukawa D, Hori T. Aggressive Graphic/Surgical R0 Resection and Jejunal Interposition with Preservation of Mesojejunal Autonomic Nerves in Patients with Stage IV Esophagogastric Junction Adenocarcinoma: A Report of 3 Cases. Am J Case Rep. 2019;20:465-473. [PMID: 30952831 DOI: 10.12659/ajcr.913960] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
176 Jo DH, Jeong O, Sun JW, Jeong MR, Ryu SY, Park YK. Feasibility study of early oral intake after gastrectomy for gastric carcinoma. J Gastric Cancer 2011;11:101-8. [PMID: 22076210 DOI: 10.5230/jgc.2011.11.2.101] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
177 Blakely AM, Miner TJ. Surgical considerations in the treatment of gastric cancer. Gastroenterol Clin North Am. 2013;42:337-357. [PMID: 23639644 DOI: 10.1016/j.gtc.2013.01.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
178 Wang FH, Shen L, Li J, Zhou ZW, Liang H, Zhang XT, Tang L, Xin Y, Jin J, Zhang YJ, Yuan XL, Liu TS, Li GX, Wu Q, Xu HM, Ji JF, Li YF, Wang X, Yu S, Liu H, Guan WL, Xu RH. The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer. Cancer Commun (Lond). 2019;39:10. [PMID: 30885279 DOI: 10.1186/s40880-019-0349-9] [Cited by in Crossref: 123] [Cited by in F6Publishing: 120] [Article Influence: 41.0] [Reference Citation Analysis]
179 Bickenbach K, Strong VE. Comparisons of Gastric Cancer Treatments: East vs. West. J Gastric Cancer. 2012;12:55-62. [PMID: 22792517 DOI: 10.5230/jgc.2012.12.2.55] [Cited by in Crossref: 80] [Cited by in F6Publishing: 85] [Article Influence: 8.0] [Reference Citation Analysis]
180 Tegels JJ, De Maat MF, Hulsewé KW, Hoofwijk AG, Stoot JH. Improving the outcomes in gastric cancer surgery. World J Gastroenterol 2014; 20(38): 13692-13704 [PMID: 25320507 DOI: 10.3748/wjg.v20.i38.13692] [Cited by in CrossRef: 39] [Cited by in F6Publishing: 29] [Article Influence: 4.9] [Reference Citation Analysis]
181 Ito S, Ito Y, Misawa K, Shimizu Y, Kinoshita T. Neoadjuvant chemotherapy followed by surgery in gastric cancer patients with extensive lymph node metastasis. World J Clin Oncol 2015; 6(6): 291-294 [PMID: 26677442 DOI: 10.5306/wjco.v6.i6.291] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
182 Bagante F, Tran T, Spolverato G, Ruzzenente A, Buttner S, Ethun CG, Groot Koerkamp B, Conci S, Idrees K, Isom CA, Fields RC, Krasnick B, Weber SM, Salem A, Martin RC, Scoggins C, Shen P, Mogal HD, Schmidt C, Beal E, Hatzaras I, Vitiello G, IJzermans JN, Maithel SK, Poultsides G, Guglielmi A, Pawlik TM. Perihilar Cholangiocarcinoma: Number of Nodes Examined and Optimal Lymph Node Prognostic Scheme. J Am Coll Surg. 2016;222:750-759.e2. [PMID: 27113512 DOI: 10.1016/j.jamcollsurg.2016.02.012] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 5.2] [Reference Citation Analysis]
183 Thomson IG, Gotley DC, Barbour AP, Martin I, Jayasuria N, Thomas J, Smithers BM. Treatment results of curative gastric resection from a specialist Australian unit: low volume with satisfactory outcomes. Gastric Cancer. 2014;17:152-160. [PMID: 23474836 DOI: 10.1007/s10120-013-0240-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
184 Colvin H, Mizushima T, Eguchi H, Takiguchi S, Doki Y, Mori M. Gastroenterological surgery in Japan: The past, the present and the future. Ann Gastroenterol Surg 2017;1:5-10. [PMID: 29863129 DOI: 10.1002/ags3.12008] [Cited by in Crossref: 110] [Cited by in F6Publishing: 83] [Article Influence: 22.0] [Reference Citation Analysis]
185 Song H, Wang T, Tian L, Bai S, Chen L, Zuo Y, Xue Y. Macrophages on the Peritoneum are involved in Gastric Cancer Peritoneal Metastasis. J Cancer 2019;10:5377-87. [PMID: 31632482 DOI: 10.7150/jca.31787] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
186 Chen Y, Lin WS, Zhu WF, Lin J, Zhou ZF, Huang CZ, Chen G, Shi Y, Guo ZQ, Ye YB. Tumor MICA status predicts the efficacy of immunotherapy with cytokine-induced killer cells for patients with gastric cancer. Immunol Res 2016;64:251-9. [PMID: 26607264 DOI: 10.1007/s12026-015-8743-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
187 Kiyokawa T, Fukagawa T. Recent trends from the results of clinical trials on gastric cancer surgery. Cancer Commun (Lond) 2019;39:11. [PMID: 30917873 DOI: 10.1186/s40880-019-0360-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
188 Douridas GN, Pierrakakis SK. Is There Any Role for D3 Lymphadenectomy in Gastric Cancer? Front Surg. 2018;5:27. [PMID: 29740588 DOI: 10.3389/fsurg.2018.00027] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
189 Sugano N, Aoyama T, Sato T, Kamiya M, Amano S, Yamamoto N, Nagashima T, Ishikawa Y, Masudo K, Taguri M, Yamanaka T, Yamamoto Y, Matsukawa H, Shiraisi R, Oshima T, Yukawa N, Rino Y, Masuda M. Randomized phase II study of TJ-54 (Yokukansan) for postoperative delirium in gastrointestinal and lung malignancy patients. Mol Clin Oncol 2017;7:569-73. [PMID: 28855990 DOI: 10.3892/mco.2017.1357] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
190 Ohe H, Lee WY, Hong SW, Chang YG, Lee B. Prognostic value of the distance of proximal resection margin in patients who have undergone curative gastric cancer surgery. World J Surg Oncol. 2014;12:296. [PMID: 25248556 DOI: 10.1186/1477-7819-12-296] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
191 Crisan A, Badulescu F, Badulescu A, Simionescu C, Andrei I, Cimpeanu R. Clinical, Histological and Prognosis Correlations in Diagnosis and Treatment of Gastric Cancer. Curr Health Sci J 2016;42:238-56. [PMID: 30581578 DOI: 10.12865/CHSJ.42.03.04] [Reference Citation Analysis]
192 Bencivenga M, Verlato G, Mengardo V, Scorsone L, Sacco M, Torroni L, Giacopuzzi S, de Manzoni G. Is There Any Role for Super-Extended Limphadenectomy in Advanced Gastric Cancer? Results of an Observational Study from a Western High Volume Center. J Clin Med 2019;8:E1799. [PMID: 31717854 DOI: 10.3390/jcm8111799] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
193 Xu J, Shen L, Shui Y, Yu W, Guo Q, Yu R, Wu Y, Wei Q. Patterns of recurrence after curative D2 resection for gastric cancer: Implications for postoperative radiotherapy. Cancer Med 2020;9:4724-35. [PMID: 32420703 DOI: 10.1002/cam4.3085] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
194 Yang K, Hu JK. Gastric cancer treatment: similarity and difference between China and Korea. Transl Gastroenterol Hepatol 2017;2:36. [PMID: 28529990 DOI: 10.21037/tgh.2017.04.02] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
195 Altan B, Yokobori T, Ide M, Mochiki E, Toyomasu Y, Kogure N, Kimura A, Hara K, Bai T, Bao P, Suzuki M, Ogata K, Asao T, Nishiyama M, Oyama T, Kuwano H. Nuclear PRMT1 expression is associated with poor prognosis and chemosensitivity in gastric cancer patients. Gastric Cancer. 2016;19:789-797. [PMID: 26472729 DOI: 10.1007/s10120-015-0551-7] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
196 Inaki N, Etoh T, Ohyama T, Uchiyama K, Katada N, Koeda K, Yoshida K, Takagane A, Kojima K, Sakuramoto S, Shiraishi N, Kitano S. A Multi-institutional, Prospective, Phase II Feasibility Study of Laparoscopy-Assisted Distal Gastrectomy with D2 Lymph Node Dissection for Locally Advanced Gastric Cancer (JLSSG0901). World J Surg. 2015;39:2734-2741. [PMID: 26170158 DOI: 10.1007/s00268-015-3160-z] [Cited by in Crossref: 134] [Cited by in F6Publishing: 127] [Article Influence: 22.3] [Reference Citation Analysis]
197 Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer. 2017;20:1-19. [PMID: 27342689 DOI: 10.1007/s10120-016-0622-4] [Cited by in Crossref: 1265] [Cited by in F6Publishing: 1149] [Article Influence: 210.8] [Reference Citation Analysis]
198 Ushimaru Y, Nishikawa K, Yasuhara Y, Kawabata R, Makari Y, Fujita J, Kitagawa A, Ohara N, Miyake Y, Maeda S, Nakahira S, Nakata K, Miyamoto A. Successful laparoscopic conversion surgery for gastric cancer with para-aortic lymph node metastasis after third-line chemotherapy: a case report. Int Cancer Conf J 2021;:1-7. [PMID: 34660169 DOI: 10.1007/s13691-021-00516-9] [Reference Citation Analysis]
199 Liang Y, Cui J, Cai Y, Liu L, Zhou J, Li Q, Wu J, He D. "D2 plus" lymphadenectomy is associated with improved survival in distal gastric cancer with clinical serosa invasion: a propensity score analysis. Sci Rep 2019;9:19186. [PMID: 31844139 DOI: 10.1038/s41598-019-55535-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
200 Charruf AZ, Ramos MFKP, Pereira MA, Dias AR, de Castria TB, Zilberstein B, Cecconelo I, Ribeiro U. Impact of neoadjuvant chemotherapy on surgical and pathological results of gastric cancer patients: A case-control study. J Surg Oncol 2020;121:833-9. [PMID: 31943232 DOI: 10.1002/jso.25839] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
201 Shimizu S, Saito H, Kono Y, Murakami Y, Shishido Y, Miyatani K, Matsunaga T, Fukumoto Y, Fujiwara Y. The prognostic significance of the comprehensive complication index in patients with gastric cancer. Surg Today 2019;49:913-20. [PMID: 31147763 DOI: 10.1007/s00595-019-01828-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
202 Lee JH, Kim KM, Cheong JH, Noh SH. Current management and future strategies of gastric cancer. Yonsei Med J 2012;53:248-57. [PMID: 22318810 DOI: 10.3349/ymj.2012.53.2.248] [Cited by in Crossref: 44] [Cited by in F6Publishing: 34] [Article Influence: 4.4] [Reference Citation Analysis]
203 Kurokawa Y, Sasako M. The Asian Perspective on the Surgical and Adjuvant Management of Esophagogastric Cancer. Surg Oncol Clin N Am 2017;26:213-24. [PMID: 28279465 DOI: 10.1016/j.soc.2016.10.011] [Reference Citation Analysis]
204 Aytaç E, Aslan F, Çicek B, Erdamar S, Gürses B, Güven K, Falay O, Karahasanoğlu T, Selçukbiricik F, Selek U, Atalar B, Balık E, Tözün N, Rozanes İ, Arıcan A, Hamzaoğlu İ, Baca B, Molinas Mandel N, Saruç M, Göksel S, Demir G, Ağaoğlu F, Yakıcıer C, Özbek U, Özben V, Özyar E, Güner AL, Er Ö, Kaban K, Bölükbaşı Y, Buğra D, Group Tİ. Dealing with the gray zones in the management of gastric cancer: The consensus statement of the İstanbul Group. Turk J Gastroenterol 2019;30:584-98. [PMID: 30541724 DOI: 10.5152/tjg.2018.18737] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
205 Wong J, Jackson P. Gastric cancer surgery: an American perspective on the current options and standards. Curr Treat Options Oncol. 2011;12:72-84. [PMID: 21274666 DOI: 10.1007/s11864-010-0136-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
206 Kim MH, Zhang X, Jung M, Jung I, Park HS, Beom SH, Kim HS, Rha SY, Kim H, Choi YY, Son T, Kim HI, Cheong JH, Hyung WJ, Noh SH, Chung HC. Immunohistochemistry Biomarkers Predict Survival in Stage II/III Gastric Cancer Patients: From a Prospective Clinical Trial. Cancer Res Treat 2019;51:819-31. [PMID: 30282452 DOI: 10.4143/crt.2018.331] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
207 Wang Y, Yu YY, Li W, Feng Y, Hou J, Ji Y, Sun YH, Shen KT, Shen ZB, Qin XY, Liu TS. A phase II trial of Xeloda and oxaliplatin (XELOX) neo-adjuvant chemotherapy followed by surgery for advanced gastric cancer patients with para-aortic lymph node metastasis. Cancer Chemother Pharmacol. 2014;73:1155-1161. [PMID: 24748418 DOI: 10.1007/s00280-014-2449-1] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 4.9] [Reference Citation Analysis]
208 Hikage M, Fujiya K, Kamiya S, Tanizawa Y, Bando E, Notsu A, Terashima M. Prognostic factors in patients who received paraaortic lymph node dissection for locally advanced gastric cancer with extensive lymph node metastasis. Langenbecks Arch Surg 2022. [PMID: 35022832 DOI: 10.1007/s00423-021-02397-1] [Reference Citation Analysis]
209 Terashima M, Tokunaga M, Tanizawa Y, Bando E, Kawamura T, Miki Y, Makuuchi R, Honda S, Tatsubayashi T, Takagi W, Omori H, Hirata F. Robotic surgery for gastric cancer. Gastric Cancer 2015;18:449-57. [PMID: 25899666 DOI: 10.1007/s10120-015-0501-4] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 4.4] [Reference Citation Analysis]
210 Yamada T, Hayashi T, Cho H, Yoshikawa T, Taniguchi H, Fukushima R, Tsuburaya A. Usefulness of enhanced recovery after surgery protocol as compared with conventional perioperative care in gastric surgery. Gastric Cancer. 2012;15:34-41. [PMID: 21573918 DOI: 10.1007/s10120-011-0057-x] [Cited by in Crossref: 104] [Cited by in F6Publishing: 93] [Article Influence: 9.5] [Reference Citation Analysis]
211 Kim DH, Yun HY, Ryu DH, Han HS, Han JH, Yoon SM, Youn SJ. Preoperative CA 125 is significant indicator of curative resection in gastric cancer patients. World J Gastroenterol 2015; 21(4): 1216-1221 [PMID: 25632195 DOI: 10.3748/wjg.v21.i4.1216] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
212 Sydiuk A. Current practice for gastric cancer treatment in Ukraine. Transl Gastroenterol Hepatol 2017;2:47. [PMID: 28616603 DOI: 10.21037/tgh.2017.04.07] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
213 Etoh T, Shiraishi N, Inomata M. Notes on laparoscopic gastrointestinal surgery-current status from clinical studies of minimally invasive surgery for gastric cancer. J Vis Surg 2017;3:14. [PMID: 29078577 DOI: 10.21037/jovs.2017.01.12] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
214 Schuhmacher C, Novotny A, Meyer HJ. [Treatment of gastric cancer beyond current guideline: state of the art]. Chirurg 2013;84:310-5. [PMID: 23479274 DOI: 10.1007/s00104-012-2454-z] [Reference Citation Analysis]
215 Choi YY, Noh SH, Cheong JH. Evolution of Gastric Cancer Treatment: From the Golden Age of Surgery to an Era of Precision Medicine. Yonsei Med J 2015;56:1177-85. [PMID: 26256958 DOI: 10.3349/ymj.2015.56.5.1177] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 6.0] [Reference Citation Analysis]
216 Shirasu H, Tsushima T, Kawahira M, Kawai S, Kawakami T, Kito Y, Yoshida Y, Hamauchi S, Todaka A, Yokota T, Machida N, Yamazaki K, Fukutomi A, Onozawa Y, Terashima M, Uesaka K, Yasui H. Role of hepatectomy in gastric cancer with multiple liver-limited metastases. Gastric Cancer. 2018;21:338-344. [PMID: 28577228 DOI: 10.1007/s10120-017-0730-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
217 Khomyakov V, Ryabov A, Ivanov A, Bolotina L, Utkina A, Volchenko N, Kaprin A. Bidirectional chemotherapy in gastric cancer with peritoneal metastasis combining intravenous XELOX with intraperitoneal chemotherapy with low-dose cisplatin and Doxorubicin administered as a pressurized aerosol: an open-label, Phase-2 study (PIPAC-GA2). Pleura Peritoneum 2016;1:159-66. [PMID: 30911619 DOI: 10.1515/pp-2016-0017] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
218 Feng F, Ji G, Li JP, Li XH, Shi H, Zhao ZW, Wu GS, Liu XN, Zhao QC. Fast-track surgery could improve postoperative recovery in radical total gastrectomy patients. World J Gastroenterol 2013; 19(23): 3642-3648 [PMID: 23801867 DOI: 10.3748/wjg.v19.i23.3642] [Cited by in CrossRef: 59] [Cited by in F6Publishing: 57] [Article Influence: 6.6] [Reference Citation Analysis]
219 Yoshikawa T, Takeuchi H, Hasegawa S, Nozaki I, Kishi K, Ito S, Ohi M, Mine S, Hara J, Matsuda T, Hiki N, Kurokawa Y. Theoretical therapeutic impact of lymph node dissection on adenocarcinoma and squamous cell carcinoma of the esophagogastric junction. Gastric Cancer. 2016;19:143-149. [PMID: 25414051 DOI: 10.1007/s10120-014-0439-y] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
220 Jiang X, Hiki N, Nunobe S, Kumagai K, Kubota T, Aikou S, Sano T, Yamaguchi T. Prognostic importance of the inflammation-based Glasgow prognostic score in patients with gastric cancer. Br J Cancer. 2012;107:275-279. [PMID: 22713657 DOI: 10.1038/bjc.2012.262] [Cited by in Crossref: 78] [Cited by in F6Publishing: 73] [Article Influence: 7.8] [Reference Citation Analysis]
221 Yanagimoto Y, Kurokawa Y, Doki Y, Yoshikawa T, Boku N, Terashima M. Surgical and perioperative treatment strategy for resectable esophagogastric junction cancer. Jpn J Clin Oncol 2022:hyac019. [PMID: 35246684 DOI: 10.1093/jjco/hyac019] [Reference Citation Analysis]
222 Procopiuc L, Tudor Ş, Mănuc M, Diculescu M, Vasilescu C. Robot-assisted surgery for gastric cancer. World J Gastrointest Oncol 2016; 8(1): 8-17 [PMID: 26798433 DOI: 10.4251/wjgo.v8.i1.8] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
223 Verlato G, Giacopuzzi S, Bencivenga M, Morgagni P, Manzoni GD. Problems faced by evidence-based medicine in evaluating lymphadenectomy for gastric cancer. World J Gastroenterol 2014; 20(36): 12883-12891 [PMID: 25278685 DOI: 10.3748/wjg.v20.i36.12883] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
224 Alkhaffaf B, Blazeby JM, Williamson PR, Bruce IA, Glenny AM. Reporting of outcomes in gastric cancer surgery trials: a systematic review. BMJ Open 2018;8:e021796. [PMID: 30337308 DOI: 10.1136/bmjopen-2018-021796] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
225 Yu J, Gao Y, Chen L, Wu D, Shen Q, Zhao Z, Liu W, Yang H, Zhang Q, Wang X, Hu P, Zheng Z, Wang X, Liu H, Xu Z, Yan Z, Wu Y, Jin M, Zhang Q, Liu X, Zhu K, Shou C. Effect of S-1 Plus Oxaliplatin Compared With Fluorouracil, Leucovorin Plus Oxaliplatin as Perioperative Chemotherapy for Locally Advanced, Resectable Gastric Cancer: A Randomized Clinical Trial. JAMA Netw Open 2022;5:e220426. [PMID: 35226081 DOI: 10.1001/jamanetworkopen.2022.0426] [Reference Citation Analysis]
226 Elimova E, Mizrak Kaya D, Harada K, Ajani JA. Potentially Curable Cancers of the Esophagus and Stomach. Mayo Clin Proc 2016;91:1307-18. [PMID: 27594190 DOI: 10.1016/j.mayocp.2016.07.018] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
227 Guner A, Yildirim R. Surgical management of metastatic gastric cancer: moving beyond the guidelines. Transl Gastroenterol Hepatol 2019;4:58. [PMID: 31559339 DOI: 10.21037/tgh.2019.08.03] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
228 Ashraf N, Hoffe S, Kim R. Adjuvant treatment for gastric cancer: chemotherapy versus radiation. Oncologist 2013;18:1013-21. [PMID: 23966224 DOI: 10.1634/theoncologist.2012-0462] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
229 Ahmed SMU, Jiang ZN, Zheng ZH, Li Y, Wang XJ, Tang X. AKR1B10 expression predicts response of gastric cancer to neoadjuvant chemotherapy. Oncol Lett 2019;17:773-80. [PMID: 30655829 DOI: 10.3892/ol.2018.9705] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
230 Lu JY, Xu L, Xue HD, Zhou WX, Xu T, Qiu HZ, Wu B, Lin GL, Xiao Y. The Radical Extent of lymphadenectomy - D2 dissection versus complete mesocolic excision of LAparoscopic Right Colectomy for right-sided colon cancer (RELARC) trial: study protocol for a randomized controlled trial. Trials 2016;17:582. [PMID: 27931247 DOI: 10.1186/s13063-016-1710-9] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 4.3] [Reference Citation Analysis]
231 Shishido Y, Fujitani K, Yamamoto K, Hirao M, Tsujinaka T, Sekimoto M. C-reactive protein on postoperative day 3 as a predictor of infectious complications following gastric cancer resection. Gastric Cancer. 2016;19:293-301. [PMID: 25560875 DOI: 10.1007/s10120-014-0455-y] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 4.6] [Reference Citation Analysis]
232 Zhang CD, Yamashita H, Seto Y. Gastric cancer surgery: historical background and perspective in Western countries versus Japan. Ann Trans Med. 2019;7(18):493. [PMID: 31700929 DOI: 10.21037/atm.2019.08.48] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
233 Garg PK, Jakhetiya A, Sharma J, Ray MD, Pandey D. Lymphadenectomy in gastric cancer: Contentious issues. World J Gastrointest Surg 2016; 8(4): 294-300 [PMID: 27152135 DOI: 10.4240/wjgs.v8.i4.294] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
234 Ott K, Lordick F, Blank S, Büchler M. Gastric cancer: surgery in 2011. Langenbecks Arch Surg 2011;396:743-58. [PMID: 21234760 DOI: 10.1007/s00423-010-0738-7] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 2.8] [Reference Citation Analysis]
235 Arai H, Nakajima TE. Recent Developments of Systemic Chemotherapy for Gastric Cancer. Cancers (Basel) 2020;12:E1100. [PMID: 32354119 DOI: 10.3390/cancers12051100] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
236 Mihmanli M, Ilhan E, Idiz UO, Alemdar A, Demir U. Recent developments and innovations in gastric cancer. World J Gastroenterol 2016; 22(17): 4307-4320 [PMID: 27158199 DOI: 10.3748/wjg.v22.i17.4307] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 43] [Article Influence: 6.8] [Reference Citation Analysis]
237 Mocellin S, McCulloch P, Kazi H, Gama-Rodrigues JJ, Yuan Y, Nitti D. Extent of lymph node dissection for adenocarcinoma of the stomach. Cochrane Database Syst Rev 2015;:CD001964. [PMID: 26267122 DOI: 10.1002/14651858.CD001964.pub4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.9] [Reference Citation Analysis]
238 Sakimura Y, Inaki N, Tsuji T, Kadoya S, Bando H. Long-term outcomes of omentum-preserving versus resecting gastrectomy for locally advanced gastric cancer with propensity score analysis. Sci Rep 2020;10:16305. [PMID: 33004919 DOI: 10.1038/s41598-020-73367-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
239 Fiorica F, Trovò M, Ottaiano A, Nasti G, Carandina I, Marzola M, De Paoli P, Berretta M. Can the addition of radiotherapy postoperatively increase clinical outcome of patients with gastric cancer? A systematic review of the literature and meta-analysis. Oncotarget 2018;9:10734-44. [PMID: 29535839 DOI: 10.18632/oncotarget.23754] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
240 Lam S, Tan E, Menezes A, Martin D, Gallagher J, Storey D, Sandroussi C. A comparison of the operative outcomes of D1 and D2 gastrectomy performed at a single Western center with multiple surgeons: a retrospective analysis with propensity score matching. World J Surg Oncol 2018;16:136. [PMID: 29986713 DOI: 10.1186/s12957-018-1422-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
241 Zhang J, Zou S, Luo R, Zhu Z, Wang Z, Xu H, Huang B. Is it worthy of adding dissection of the superior mesenteric vein lymph node (14v) to standard D2 gastrectomy for distal gastric cancers with No. 6 lymph node metastasis? Clin Transl Oncol. 2019;. [PMID: 30977046 DOI: 10.1007/s12094-019-02103-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
242 Hoang T, Dayyani F, Alfaro A, Huynh J, Ji J, Ko AH, Cho M, Hiyama D. Variability in multimodality treatment influences survival in non-metastatic gastric cancer patients. J Gastrointest Oncol 2020;11:952-63. [PMID: 33209490 DOI: 10.21037/jgo-20-212] [Reference Citation Analysis]
243 Gu L, Zhang K, Shen Z, Wang X, Zhu H, Pan J, Zhong X, Khadaroo PA, Chen P. Risk Factors for Duodenal Stump Leakage after Laparoscopic Gastrectomy for Gastric Cancer. J Gastric Cancer 2020;20:81-94. [PMID: 32269847 DOI: 10.5230/jgc.2020.20.e4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
244 Li L, Zhang S, Xie D, Chen H, Zheng X, Pan D. Dual inhibitor of PI3K and mTOR (NVP-BEZ235) augments the efficacy of fluorouracil on gastric cancer chemotherapy. Onco Targets Ther 2018;11:6111-8. [PMID: 30275715 DOI: 10.2147/OTT.S172957] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
245 Narayan RR, Poultsides GA. Advances in the surgical management of gastric and gastroesophageal junction cancer. Transl Gastroenterol Hepatol 2021;6:16. [PMID: 33409410 DOI: 10.21037/tgh.2020.02.06] [Reference Citation Analysis]
246 Dong YP, Deng JY. Advances in para-aortic nodal dissection in gastric cancer surgery: A review of research progress over the last decade. World J Clin Cases 2020; 8(13): 2703-2716 [PMID: 32742981 DOI: 10.12998/wjcc.v8.i13.2703] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
247 Sun L, Zhou P, Hua Q, Jin C, Guo C, Song B. Effects of blood glucose, blood lipids and blood pressure control on recovery of patients with gastric cancer complicated with metabolic syndrome after radical gastrectomy. Exp Ther Med 2018;15:4785-90. [PMID: 29805496 DOI: 10.3892/etm.2018.6033] [Reference Citation Analysis]
248 Tanigawa N, Nomura E, Lee SW, Kaminishi M, Sugiyama M, Aikou T, Kitajima M; Society for the Study of Postoperative Morbidity after Gastrectomy. Current state of gastric stump carcinoma in Japan: based on the results of a nationwide survey. World J Surg. 2010;34:1540-1547. [PMID: 20182716 DOI: 10.1007/s00268-010-0505-5] [Cited by in Crossref: 55] [Cited by in F6Publishing: 59] [Article Influence: 5.0] [Reference Citation Analysis]
249 Tang Z, Wang Y, Yu Y, Cui Y, Liang L, Xu C, Shen Z, Shen K, Wang X, Liu T, Sun Y. Neoadjuvant apatinib combined with oxaliplatin and capecitabine in patients with locally advanced adenocarcinoma of stomach or gastroesophageal junction: a single-arm, open-label, phase 2 trial. BMC Med 2022;20:107. [PMID: 35382819 DOI: 10.1186/s12916-022-02309-0] [Reference Citation Analysis]
250 Blakely AM, Miner TJ. Surgical considerations in the treatment of gastric cancer. Gastroenterol Clin North Am. 2013;42:337-357. [PMID: 23639644 DOI: 10.1016/j.gtc.2013.01.010.surgical] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
251 Saito H, Kono Y, Murakami Y, Shishido Y, Kuroda H, Matsunaga T, Fukumoto Y, Osaki T, Ashida K, Fujiwara Y. Therapeutic Value of Lymph Node Dissection Along the Superior Mesenteric Vein and the Posterior Surface of the Pancreatic Head in Gastric Cancer Located in the Lower Third of the Stomach. Yonago Acta Med. 2018;61:175-181. [PMID: 30275748 DOI: 10.33160/yam.2018.09.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
252 Morita S, Fukagawa T, Fujiwara H, Katai H. Questionnaire survey regarding the current status of super-extended lymph node dissection in Japan. World J Gastrointest Oncol 2016; 8(9): 707-714 [PMID: 27672429 DOI: 10.4251/wjgo.v8.i9.707] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
253 Seshadri RA, Glehen O. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gastric cancer. World J Gastroenterol 2016; 22(3): 1114-1130 [PMID: 26811651 DOI: 10.3748/wjg.v22.i3.1114] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 29] [Article Influence: 5.8] [Reference Citation Analysis]
254 Tanizawa Y, Terashima M. Lymph node dissection in the resection of gastric cancer: review of existing evidence. Gastric Cancer. 2010;13:137-148. [PMID: 20820982 DOI: 10.1007/s10120-010-0560-5] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 3.3] [Reference Citation Analysis]
255 Nilsson M, Rouvelas I, Irino T, Kamiya S, Hayami M, Lindblad M. Correspondence. Br J Surg 2019;106:152-3. [PMID: 30582636 DOI: 10.1002/bjs.11077] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
256 Liang Y, Wu L, Wang X, Ding X, Liu H, Li B, Wang B, Pan Y, Zhang R, Liu N, Liang H. Positive impact of adding No.14v lymph node to D2 dissection on survival for distal gastric cancer patients after surgery with curative intent. Chin J Cancer Res. 2015;27:580-587. [PMID: 26752932 DOI: 10.3978/j.issn.1000-9604.2015.12.02] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
257 Chen C, Dong H, Shou C, Shi X, Zhang Q, Liu X, Zhu K, Zhong B, Yu J. The Correlation Between Computed Tomography Volumetry and Prognosis of Advanced Gastric Cancer Treated with Neoadjuvant Chemotherapy. Cancer Manag Res 2020;12:759-68. [PMID: 32099471 DOI: 10.2147/CMAR.S231636] [Reference Citation Analysis]
258 Degiuli M, De Manzoni G, Di Leo A, D’Ugo D, Galasso E, Marrelli D, Petrioli R, Polom K, Roviello F, Santullo F, Morino M. Gastric cancer: Current status of lymph node dissection. World J Gastroenterol 2016; 22(10): 2875-2893 [PMID: 26973384 DOI: 10.3748/wjg.v22.i10.2875] [Cited by in CrossRef: 57] [Cited by in F6Publishing: 52] [Article Influence: 9.5] [Reference Citation Analysis]
259 Hayashi S, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y. Number of retrieved lymph nodes is an independent prognostic factor after total gastrectomy for patients with stage III gastric cancer: propensity score matching analysis of a multi-institution dataset. Gastric Cancer. 2019;22:853-863. [PMID: 30483985 DOI: 10.1007/s10120-018-0902-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
260 Uslu A, Zengel B, İlhan E, Aykas A, Şimşek C, Üreyen O, Duran A, Okut G. Survival outcomes after D1 and D2 lymphadenectomy with R0 resection in stage II-III gastric cancer: Longitudinal follow-up in a single center. Turk J Surg 2018;34:125-30. [PMID: 30023977 DOI: 10.5152/turkjsurg.2018.3846] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
261 Hartgrink HH. Should we remove splenic hilus lymph nodes for esophagogastric junction adenocarcinoma? Gastric Cancer 2013;16:454-6. [PMID: 23417699 DOI: 10.1007/s10120-013-0237-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
262 Choi YY, Cho M, Kwon IG, Son T, Kim HI, Choi SH, Cheong JH, Hyung WJ. Ten Thousand Consecutive Gastrectomies for Gastric Cancer: Perspectives of a Master Surgeon. Yonsei Med J 2019;60:235-42. [PMID: 30799586 DOI: 10.3349/ymj.2019.60.3.235] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
263 Brisinda G, Crocco A, Tomaiuolo P, Santullo F, Mazzari A, Vanella S. Extended or limited lymph node dissection? A gastric cancer surgical dilemma. Ann Surg 2012;256:e30-1. [PMID: 23108130 DOI: 10.1097/SLA.0b013e31827693c3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
264 Lin JX, Lin JP, Xie JW, Wang JB, Lu J, Chen QY, Cao LL, Lin M, Tu R, Zheng CH, Huang CM, Li P. Prognostic Value and Association of Sarcopenia and Systemic Inflammation for Patients with Gastric Cancer Following Radical Gastrectomy. Oncologist. 2019;24:e1091-e1101. [PMID: 30910865 DOI: 10.1634/theoncologist.2018-0651] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
265 Chen XZ, Wen L, Rui YY, Liu CX, Zhao QC, Zhou ZG, Hu JK. Long-term survival outcomes of laparoscopic versus open gastrectomy for gastric cancer: a systematic review and meta-analysis. Medicine (Baltimore). 2015;94:e454. [PMID: 25634185 DOI: 10.1097/md.0000000000000454] [Cited by in Crossref: 28] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
266 Blouhos K, Boulas KA, Tsalis K, Barettas N, Aftzoglou M, Hatzigeorgiadis A. Report of two Cases with Metastasis in Lymph NodesAlong the Posterior Leaf of the Bursa Omentalis at the Area of the Pancreatic Body, an Area not Routinely Examined in Standard Gastrectomy Plus Bursectomy for Advanced Gastric Cancer. J Gastrointest Cancer 2016;47:436-41. [PMID: 26334194 DOI: 10.1007/s12029-015-9756-6] [Reference Citation Analysis]
267 Lee JH, Nam BH, Ryu KW, Ryu SY, Kim YW, Park YK, Kim S. Comparison of the long-term results of patients who underwent laparoscopy versus open distal gastrectomy. Surg Endosc. 2016;30:430-436. [PMID: 25875090 DOI: 10.1007/s00464-015-4215-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
268 Matsuda T, Takeuchi H, Tsuwano S, Nakamura R, Takahashi T, Wada N, Kawakubo H, Saikawa Y, Omori T, Kitagawa Y. Optimal surgical management for esophagogastric junction carcinoma. Gen Thorac Cardiovasc Surg 2014;62:560-6. [PMID: 24570201 DOI: 10.1007/s11748-014-0381-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
269 Brenkman HJF, Goense L, Brosens LA, Haj Mohammad N, Vleggaar FP, Ruurda JP, van Hillegersberg R. A High Lymph Node Yield is Associated with Prolonged Survival in Elderly Patients Undergoing Curative Gastrectomy for Cancer: A Dutch Population-Based Cohort Study. Ann Surg Oncol 2017;24:2213-23. [PMID: 28247154 DOI: 10.1245/s10434-017-5815-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
270 Shinozuka T, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y. D2 lymph node dissection confers little benefit on the overall survival of older patients with resectable gastric cancer: a propensity score-matching analysis of a multi-institutional dataset. Surg Today 2020;50:1434-42. [PMID: 32451713 DOI: 10.1007/s00595-020-02021-7] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
271 Ludmir EB, Das P. Shifting sands: the role of radiotherapy for patients with gastric and gastroesophageal adenocarcinoma. Transl Gastroenterol Hepatol 2021;6:50. [PMID: 34423171 DOI: 10.21037/tgh.2020.03.01] [Reference Citation Analysis]
272 Imamura H, Kurokawa Y, Kawada J, Tsujinaka T, Takiguchi S, Fujiwara Y, Mori M, Doki Y. Influence of bursectomy on operative morbidity and mortality after radical gastrectomy for gastric cancer: results of a randomized controlled trial. World J Surg. 2011;35:625-630. [PMID: 21161652 DOI: 10.1007/s00268-010-0914-5] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 3.1] [Reference Citation Analysis]
273 Kauff DW, Babic B, Grimminger PP, Kneist W, Lang H. [Lymphadenectomy in oncological visceral surgery-Part 2 : Cancer of the upper and lower intestinal tract]. Chirurg 2019;90:505-21. [PMID: 31119337 DOI: 10.1007/s00104-019-0963-8] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
274 Kong P, Wu R, Yang C, Geng Q, Liu J, Chen S, Liu X, Ye M, He W, Yang Q, Xia L, Xu D. Prognostic Impact of the Signet Ring Cell Type in Node-Negative Gastric Cancer. Sci Rep 2016;6:26313. [PMID: 27381549 DOI: 10.1038/srep26313] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
275 Zhan Z, Wang X, Yu J, Zheng J, Zeng Y, Sun M, Peng L, Guo Z, Chen B. Intraperitoneal infusion of recombinant human indentation improves prognosis in gastric cancer ascites. Future Oncol 2022;:523-31. [PMID: 35114805 DOI: 10.2217/fon-2021-0896] [Reference Citation Analysis]
276 Zhu X, Zhou G, Ma M, Hou D, Huang H, Jiang X, Xing PhD C. Clinicopathological Analysis and Prognostic Assessment of TCN1 in Patients with Gastric Cancer. Surg Innov 2021;:15533506211045318. [PMID: 34549663 DOI: 10.1177/15533506211045318] [Reference Citation Analysis]
277 Goto H, Tokunaga M, Miki Y, Makuuchi R, Sugisawa N, Tanizawa Y, Bando E, Kawamura T, Niihara M, Tsubosa Y, Terashima M. The optimal extent of lymph node dissection for adenocarcinoma of the esophagogastric junction differs between Siewert type II and Siewert type III patients. Gastric Cancer. 2014;. [PMID: 24658651 DOI: 10.1007/s10120-014-0364-0] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 4.3] [Reference Citation Analysis]
278 Chen Y, Liu J, Wang W, Xiang L, Wang J, Liu S, Zhou H, Guo Z. High expression of hnRNPA1 promotes cell invasion by inducing EMT in gastric cancer. Oncol Rep 2018;39:1693-701. [PMID: 29484423 DOI: 10.3892/or.2018.6273] [Cited by in Crossref: 9] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
279 Wu J, Tang Z, Zhao G, Zang L, Li Z, Zang W, Li Z, Qu J, Yan S, Zheng C, Ji G, Zhu L, Zhao Y, Zhang J, Huang H, Hao Y, Fan L, Xu H, Li Y, Yang L, Song W, Zhu J, Zhang W, Li M, Qin X, Liu F. Incidence and risk factors for postoperative pancreatic fistula in 2089 patients treated by radical gastrectomy: A prospective multicenter cohort study in China. Int J Surg 2022;98:106219. [PMID: 34990829 DOI: 10.1016/j.ijsu.2021.106219] [Reference Citation Analysis]
280 Marrelli D, Polom K, Neri A, Roviello F. Clinical impact of molecular classifications in gastric cancer. Updates Surg 2018;70:225-32. [PMID: 29796937 DOI: 10.1007/s13304-018-0546-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
281 Mulder KE, Ahmed S, Davies JD, Doll CM, Dowden S, Gill S, Gordon V, Hebbard P, Lim H, McFadden A, McGhie JP, Park J, Wong R. Report from the 17th Annual Western Canadian Gastrointestinal Cancer Consensus Conference; Edmonton, Alberta; 11-12 September 2015. Curr Oncol. 2016;23:425-434. [PMID: 28050139 DOI: 10.3747/co.23.3384] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
282 Sasako M. Progress in the treatment of gastric cancer in Japan over the last 50 years. Ann Gastroenterol Surg 2020;4:21-9. [PMID: 32021955 DOI: 10.1002/ags3.12306] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
283 Rosa F, Costamagna G, Doglietto GB, Alfieri S. Classification of nodal stations in gastric cancer. Transl Gastroenterol Hepatol 2017;2:2. [PMID: 28217752 DOI: 10.21037/tgh.2016.12.03] [Cited by in Crossref: 9] [Article Influence: 1.8] [Reference Citation Analysis]
284 Huang C, Hu C, Zhu J, Zhang W, Huang J, Zhu Z. Establishment of Decision Rules and Risk Assessment Model for Preoperative Prediction of Lymph Node Metastasis in Gastric Cancer. Front Oncol 2020;10:1638. [PMID: 32984033 DOI: 10.3389/fonc.2020.01638] [Reference Citation Analysis]
285 Nam BH, Kim YW, Reim D, Eom BW, Yu WS, Park YK, Ryu KW, Lee YJ, Yoon HM, Lee JH, Jeong O, Jeong SH, Lee SE, Lee SH, Yoon KY, Seo KW, Chung HY, Kwon OK, Kim TB, Lee WK, Park SH, Sul JY, Yang DH, Lee JS. Laparoscopy Assisted versus Open Distal Gastrectomy with D2 Lymph Node Dissection for Advanced Gastric Cancer: Design and Rationale of a Phase II Randomized Controlled Multicenter Trial (COACT 1001). J Gastric Cancer 2013;13:164-71. [PMID: 24156036 DOI: 10.5230/jgc.2013.13.3.164] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
286 Blank S, Bläker H, Schaible A, Lordick F, Grenacher L, Buechler M, Ott K. Impact of pretherapeutic routine clinical staging for the individualization of treatment in gastric cancer patients. Langenbecks Arch Surg 2012;397:45-55. [PMID: 21598045 DOI: 10.1007/s00423-011-0805-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
287 Kodera Y, Kobayashi D, Tanaka C, Fujiwara M. Gastric adenocarcinoma with para-aortic lymph node metastasis: A borderline resectable cancer? Surg Today. 2015;45:1082-1090. [PMID: 25366353 DOI: 10.1007/s00595-014-1067-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
288 Orditura M, Galizia G, Sforza V, Gambardella V, Fabozzi A, Laterza MM, Andreozzi F, Ventriglia J, Savastano B, Mabilia A, Lieto E, Ciardiello F, De Vita F. Treatment of gastric cancer. World J Gastroenterol 2014; 20(7): 1635-1649 [PMID: 24587643 DOI: 10.3748/wjg.v20.i7.1635] [Cited by in CrossRef: 323] [Cited by in F6Publishing: 320] [Article Influence: 40.4] [Reference Citation Analysis]
289 Ozmen MM, Zulfikaroglu B, Ozmen F, Moran M, Ozalp N, Seckin S. D2 vs D2 Plus Para-aortic Lymph Node Dissection for Advanced Gastric Cancer. Turk J Surg 2021;37:49-58. [PMID: 34585094 DOI: 10.47717/turkjsurg.2020.4931] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
290 Xu DZ, Geng QR, Tian Y, Cai MY, Fang XJ, Zhan YQ, Zhou ZW, Li W, Chen YB, Sun XW. Activated mammalian target of rapamycin is a potential therapeutic target in gastric cancer. BMC Cancer. 2010;10:536. [PMID: 20929525 DOI: 10.1186/1471-2407-10-536] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
291 Ma LG, Xi HQ, Chen L. Conversion therapy for unresectable gastric cancer. Shijie Huaren Xiaohua Zazhi 2016; 24(4): 528-534 [DOI: 10.11569/wcjd.v24.i4.528] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
292 Nie RC, Yuan SQ, Chen S, Yan SM, Chen YM, Chen XJ, Chen GM, Zhou ZW, Chen YB, Li YF. Bursectomy for advanced gastric cancer: an update meta-analysis. World J Surg Oncol 2018;16:66. [PMID: 29592807 DOI: 10.1186/s12957-018-1354-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
293 Chen X, Zhang W, Sun X, Shi M, Xu L, Cai Y, Chen W, Mao C, Shen X. Metabolic syndrome predicts postoperative complications after gastrectomy in gastric cancer patients: Development of an individualized usable nomogram and rating model. Cancer Med 2020;9:7116-24. [PMID: 33470549 DOI: 10.1002/cam4.3352] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
294 Liu X, Chen S, Liu J, Xu D, Li W, Zhan Y, Li Y, Chen Y, Zhou Z, Sun X. Impact of systemic inflammation on gastric cancer outcomes. PLoS One. 2017;12:e0174085. [PMID: 28358923 DOI: 10.1371/journal.pone.0174085] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
295 Sun W, Deng J, Zhang N, Liu H, Liu J, Gu P, Du Y, Wu Z, He W, Wang P, Liang H. Prognostic impact of D2-plus lymphadenectomy and optimal extent of lymphadenectomy in advanced gastric antral carcinoma: Propensity score matching analysis. Chin J Cancer Res 2020;32:51-61. [PMID: 32194305 DOI: 10.21147/j.issn.1000-9604.2020.01.07] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
296 Zheng B, Ma B, Yang K, Mi D. Meta-analysis of randomized controlled trials comparing D2 and D4 lymphadenectomy for gastric cancer. Eur Surg 2011;43:255-61. [DOI: 10.1007/s10353-011-0614-x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
297 Kodera Y. Surgery with curative intent for stage IV gastric cancer: Is it a reality of illusion? Ann Gastroenterol Surg 2018;2:339-47. [PMID: 30238074 DOI: 10.1002/ags3.12191] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
298 Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer. 2011;14:113-123. [PMID: 21573742 DOI: 10.1007/s10120-011-0042-4] [Cited by in Crossref: 1577] [Cited by in F6Publishing: 1566] [Article Influence: 143.4] [Reference Citation Analysis]
299 Hanisch E, Ziogas D. Laparoscopic gastrectomy for organ-confined cancer: a reality in the West? Surg Endosc 2009;23:1924-6. [PMID: 19444509 DOI: 10.1007/s00464-009-0503-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
300 Lee JH, Kim JG, Jung HK, Kim JH, Jeong WK, Jeon TJ, Kim JM, Kim YI, Ryu KW, Kong SH, Kim HI, Jung HY, Kim YS, Zang DY, Cho JY, Park JO, Lim DH, Jung ES, Ahn HS, Kim HJ. Clinical practice guidelines for gastric cancer in Korea: an evidence-based approach. J Gastric Cancer. 2014;14:87-104. [PMID: 25061536 DOI: 10.5230/jgc.2014.14.2.87] [Cited by in Crossref: 119] [Cited by in F6Publishing: 118] [Article Influence: 14.9] [Reference Citation Analysis]
301 Yarema R, de Manzoni G, Fetsych T, Ohorchak M, Pliatsko M, Bencivenga M. On the road to standardization of D2 lymph node dissection in a European population of patients with gastric cancer. World J Gastrointest Oncol 2016; 8(6): 489-497 [PMID: 27326318 DOI: 10.4251/wjgo.v8.i6.489] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
302 Matsumoto T, Sasako M, Mizusawa J, Hirota S, Ochiai A, Kushima R, Katai H, Tanaka Y, Fukushima N, Nashimoto A, Tsuburaya A; Stomach Cancer Study Group of the Japan Clinical Oncology Group. HER2 expression in locally advanced gastric cancer with extensive lymph node (bulky N2 or paraaortic) metastasis (JCOG1005-A trial). Gastric Cancer 2015;18:467-75. [PMID: 24993498 DOI: 10.1007/s10120-014-0398-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
303 Arienti C, Pignatta S, Tesei A. Epidermal Growth Factor Receptor Family and its Role in Gastric Cancer. Front Oncol 2019;9:1308. [PMID: 31850207 DOI: 10.3389/fonc.2019.01308] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
304 Chen QY, Zheng CH, Li P, Xie JW, Wang JB, Lin JX, Lu J, Cao LL, Lin M, Tu RH, Huang ZN, Lin JL, Huang CM. Safety and prognostic impact of prophylactic laparoscopic superior mesenteric vein (No. 14v) lymph node dissection for lower-third gastric cancer: a propensity score-matched case-control study. Surg Endosc. 2018;32:1495-1505. [PMID: 28916893 DOI: 10.1007/s00464-017-5837-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
305 Geng QR, Xu DZ, He LJ, Lu JB, Zhou ZW, Zhan YQ, Lu Y. Beclin-1 expression is a significant predictor of survival in patients with lymph node-positive gastric cancer. PLoS One 2012;7:e45968. [PMID: 23029344 DOI: 10.1371/journal.pone.0045968] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
306 Yang K, Choi YY, Zhang WH, Chen XZ, Song MK, Lee J, Zhang B, Chen ZX, Kim HI, Chen JP. Strategies to improve treatment outcome in gastric cancer: a retrospective analysis of patients from two high-volume hospitals in Korea and China. Oncotarget. 2016;7:44660-44675. [PMID: 27191995 DOI: 10.18632/oncotarget.9378] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
307 Fukagawa T, Katai H, Saka M, Morita S, Sasajima Y, Taniguchi H, Sano T, Sasako M. Significance of lavage cytology in advanced gastric cancer patients. World J Surg. 2010;34:563-568. [PMID: 20054543 DOI: 10.1007/s00268-009-0355-1] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 3.0] [Reference Citation Analysis]
308 Uyama I, Suda K, Satoh S. Laparoscopic surgery for advanced gastric cancer: current status and future perspectives. J Gastric Cancer. 2013;13:19-25. [PMID: 23610715 DOI: 10.5230/jgc.2013.13.1.19] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 5.7] [Reference Citation Analysis]
309 Chen M, He FQ, Liao MS, Yang C, Chen XD. Gastrectomy with omentum preservation versus gastrectomy with omentectomy for locally advanced gastric cancer: A systematic review and meta-analysis. Int J Surg 2021;96:106176. [PMID: 34763112 DOI: 10.1016/j.ijsu.2021.106176] [Reference Citation Analysis]
310 Ekman M, Girnyi S, Marano L, Roviello F, Chand M, Diana M, Polom K. Near-Infrared Fluorescence Image-Guided Surgery in Esophageal and Gastric Cancer Operations. Surg Innov. [DOI: 10.1177/15533506211073417] [Reference Citation Analysis]
311 Brind'Amour A, Gagné JP, Hogue JC, Poirier É. Impact of the introduction of formal D2 lymphadenectomy for gastric cancer in a Western setting. Can J Surg 2021;64:E119-26. [PMID: 33651574 DOI: 10.1503/cjs.019919] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
312 Quan H, Ouyang L, Zhou H, Ouyang Y, Xiao H. The effect of preoperative smoking cessation and smoking dose on postoperative complications following radical gastrectomy for gastric cancer: a retrospective study of 2469 patients. World J Surg Oncol 2019;17:61. [PMID: 30940207 DOI: 10.1186/s12957-019-1607-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
313 Cao GD, Xu XY, Zhang JW, Chen B, Xiong MM. Phosphorylated Mammalian Target of Rapamycin p-mTOR Is a Favorable Prognostic Factor than mTOR in Gastric Cancer. PLoS One 2016;11:e0168085. [PMID: 28005970 DOI: 10.1371/journal.pone.0168085] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
314 Song W, Yuan Y, Wang L, He W, Zhang X, Chen C, Zhang C, Cai S, He Y. The prognostic value of lymph nodes dissection number on survival of patients with lymph node-negative gastric cancer. Gastroenterol Res Pract. 2014;2014:603194. [PMID: 24868201 DOI: 10.1155/2014/603194] [Cited by in Crossref: 17] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
315 Hagi T, Kurokawa Y, Mizusawa J, Fukagawa T, Katai H, Sano T, Misawa K, Fukushima N, Kawachi Y, Sasako M, Yoshikawa T, Terashima M. Impact of tumor-related factors and inter-institutional heterogeneity on preoperative T staging for gastric cancer. Future Oncol 2022. [PMID: 35582901 DOI: 10.2217/fon-2021-1069] [Reference Citation Analysis]
316 Liu X, Qiu H, Kong P, Zhou Z, Sun X. Gastric cancer, nutritional status, and outcome. Onco Targets Ther. 2017;10:2107-2114. [PMID: 28442919 DOI: 10.2147/ott.s132432] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 3.2] [Reference Citation Analysis]
317 Kim MS, Lim JS, Hyung WJ, Lee YC, Rha SY, Keum KC, Koom WS. Neoadjuvant chemoradiotherapy followed by D2 gastrectomy in locally advanced gastric cancer. World J Gastroenterol 2015; 21(9): 2711-2718 [PMID: 25759540 DOI: 10.3748/wjg.v21.i9.2711] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
318 Zheng XH, Zhang W, Yang L, Du CX, Li N, Xing GS, Tian YT, Xie YB. Role of D2 gastrectomy in gastric cancer with clinical para-aortic lymph node metastasis. World J Gastroenterol 2019; 25(19): 2338-2353 [PMID: 31148905 DOI: 10.3748/wjg.v25.i19.2338] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
319 Chen T, Yan D, Zheng Z, Yang J, Dong XDE. Evolution in the surgical management of gastric cancer: is extended lymph node dissection back in vogue in the USA? World J Surg Oncol. 2017;15:135. [PMID: 28716043 DOI: 10.1186/s12957-017-1204-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
320 Ojima T, Hayata K, Kitadani J, Yamaue H. Robotic curative para-aortic lymph node dissection via INfra-mesocolon for gastric cancer: Robotic CAVING approach. Surg Oncol 2021;39:101658. [PMID: 34624690 DOI: 10.1016/j.suronc.2021.101658] [Reference Citation Analysis]
321 Kumagai K, Sano T, Hiki N, Nunobe S, Tsujiura M, Ida S, Ohashi M, Yamaguchi T. Survival benefit of "D2-plus" gastrectomy in gastric cancer patients with duodenal invasion. Gastric Cancer. 2018;21:296-302. [PMID: 28584890 DOI: 10.1007/s10120-017-0733-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
322 Kurimoto K, Ishigure K, Mochizuki Y, Ishiyama A, Matsui T, Ito S, Nakayama H, Tanaka N, Kobayashi D, Sakamoto J, Nakao A, Kodera Y. A feasibility study of postoperative chemotherapy with S-1 and cisplatin (CDDP) for stage III/IV gastric cancer (CCOG 1106). Gastric Cancer 2015;18:354-9. [PMID: 24838732 DOI: 10.1007/s10120-014-0384-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
323 Hartgrink HH, Jansen EP, van Grieken NC, van de Velde CJ. Gastric cancer. Lancet. 2009;374:477-490. [PMID: 19625077 DOI: 10.1016/s0140-6736(09)] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
324 Lee HJ, Nam KT, Park HS, Kim MA, Lafleur BJ, Aburatani H, Yang HK, Kim WH, Goldenring JR. Gene expression profiling of metaplastic lineages identifies CDH17 as a prognostic marker in early stage gastric cancer. Gastroenterology. 2010;139:213-25.e3. [PMID: 20398667 DOI: 10.1053/j.gastro.2010.04.008] [Cited by in Crossref: 88] [Cited by in F6Publishing: 91] [Article Influence: 7.3] [Reference Citation Analysis]
325 Hikage M, Tokunaga M, Makuuchi R, Irino T, Tanizawa Y, Bando E, Kawamura T, Terashima M. Comparison of Surgical Outcomes Between Robotic and Laparoscopic Distal Gastrectomy for cT1 Gastric Cancer. World J Surg 2018;42:1803-10. [PMID: 29134310 DOI: 10.1007/s00268-017-4345-4] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
326 Liang YX, Guo HH, Deng JY, Wang BG, Ding XW, Wang XN, Zhang L, Liang H. Impact of intraoperative blood loss on survival after curative resection for gastric cancer. World J Gastroenterol 2013; 19(33): 5542-5550 [PMID: 24023499 DOI: 10.3748/wjg.v19.i33.5542] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 33] [Article Influence: 3.3] [Reference Citation Analysis]
327 Caruso S, Patriti A, Roviello F, De Franco L, Franceschini F, Ceccarelli G, Coratti A. Robot-assisted laparoscopic vs open gastrectomy for gastric cancer: Systematic review and meta-analysis. World J Clin Oncol 2017; 8(3): 273-284 [PMID: 28638798 DOI: 10.5306/wjco.v8.i3.273] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
328 Xu J, Bian YH, Jin X, Cao H. Prognostic assessment of different metastatic lymph node staging methods for gastric cancer after D2 resection. World J Gastroenterol 2013; 19(12): 1975-1983 [PMID: 23569344 DOI: 10.3748/wjg.v19.i12.1975] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
329 Zhang CD, Zeng YJ, Li Z, Chen J, Li HW, Zhang JK, Dai DQ. Extended antimicrobial prophylaxis after gastric cancer surgery: A systematic review and meta-analysis. World J Gastroenterol 2013; 19(13): 2104-2109 [PMID: 23599632 DOI: 10.3748/wjg.v19.i13.2104] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
330 Sah BK, Chen MM, Yan M, Zhu ZG. Gastric cancer surgery: Billroth I or Billroth II for distal gastrectomy? BMC Cancer 2009;9:428. [PMID: 20003202 DOI: 10.1186/1471-2407-9-428] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
331 Peng D, Cheng YX, Tao W, Zou YY, Qian K, Zhang W. Onco-Metabolic Surgery: A Combined Approach to Gastric Cancer and Hypertension.Cancer Manag Res. 2020;12:7867-7873. [PMID: 32922085 DOI: 10.2147/CMAR.S260147] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
332 Saito R, Yoshimura K, Shoda K, Furuya S, Akaike H, Kawaguchi Y, Murata T, Ogata K, Iwano T, Takeda S, Ichikawa D. Diagnostic significance of plasma lipid markers and machine learning-based algorithm for gastric cancer. Oncol Lett 2021;21:405. [PMID: 33841566 DOI: 10.3892/ol.2021.12666] [Reference Citation Analysis]
333 Khachfe HH, Salhab HA, Fares MY, Chahrour MA, Jamali FR. Landscape of interventional clinical trials involving gastrectomy for gastric cancer. Ecancermedicalscience 2021;15:1218. [PMID: 34158822 DOI: 10.3332/ecancer.2021.1218] [Reference Citation Analysis]
334 Fang WL, Huang KH, Chen MH, Liu CA, Hung YP, Chao Y, Tai LC, Lo SS, Li AF, Wu CW, Shyr YM. Comparative study of the 7th and 8th AJCC editions for gastric cancer patients after curative surgery. PLoS One 2017;12:e0187626. [PMID: 29131840 DOI: 10.1371/journal.pone.0187626] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
335 Xiao H, Quan H, Pan S, Yin B, Luo W, Huang G, Ouyang Y. Impact of peri-operative blood transfusion on post-operative infections after radical gastrectomy for gastric cancer: a propensity score matching analysis focusing on the timing, amount of transfusion and role of leukocyte depletion. J Cancer Res Clin Oncol 2018;144:1143-54. [PMID: 29572591 DOI: 10.1007/s00432-018-2630-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
336 Liakakos T, Misiakos EP, Macheras A. Advanced gastric cancer: is laparoscopic gastrectomy safe? Surg Endosc 2009;23:1161-3. [PMID: 19296172 DOI: 10.1007/s00464-009-0427-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
337 Ott K, Lordick F. [Neoadjuvant therapy in the upper gastro-intestinal tract. Gastric cancer from a surgical viewpoint]. Chirurg 2009;80:1028-34. [PMID: 19756431 DOI: 10.1007/s00104-009-1736-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
338 Li Y, Wang D, Li Y, Liu X, Chen D, Yuan C, Zhou Y. Clinical Significance of Lymph Node Micrometastasis in pN0 Gastric Cancer Patients. Gastroenterol Res Pract 2021;2021:6854646. [PMID: 33747076 DOI: 10.1155/2021/6854646] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
339 Charalampakis N, Nogueras González GM, Elimova E, Wadhwa R, Shiozaki H, Shimodaira Y, Blum MA, Rogers JE, Harada K, Matamoros A Jr, Sagebiel T, Das P, Minsky BD, Lee JH, Weston B, Bhutani MS, Estrella JS, Badgwell BD, Ajani JA. The Proportion of Signet Ring Cell Component in Patients with Localized Gastric Adenocarcinoma Correlates with the Degree of Response to Pre-Operative Chemoradiation. Oncology 2016;90:239-47. [PMID: 27046280 DOI: 10.1159/000443506] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 4.7] [Reference Citation Analysis]
340 Li C, Yan M, Chen J, Xiang M, Zhu ZG, Yin HR, Lin YZ. Survival benefit of non-curative gastrectomy for gastric cancer patients with synchronous distant metastasis. J Gastrointest Surg. 2010;14:282-288. [PMID: 19937478 DOI: 10.1007/s11605-009-1095-0] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.2] [Reference Citation Analysis]
341 Mueller JL, Kim DH, Stapleton S, Cauley CE, Chang DC, Park CH, Song KY, Mullen JT. Nature versus nurture: the impact of nativity and site of treatment on survival for gastric cancer. Gastric Cancer 2019;22:446-55. [PMID: 30167904 DOI: 10.1007/s10120-018-0869-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
342 Xiao H, Liu W, Quan H, Ouyang Y. Peri-Operative Blood Transfusion Does Not Influence Overall and Disease-Free Survival After Radical Gastrectomy for Stage II/III Gastric Cancer: a Propensity Score Matching Analysis. J Gastrointest Surg 2018;22:1489-500. [PMID: 29777453 DOI: 10.1007/s11605-018-3808-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
343 Takiguchi S, Miyazaki Y, Murakami K, Makino T, Takahashi T, Kurokawa Y, Yamasaki M, Nakajima K, Miyata H, Mori M, Doki Y. Laparoscopic lymphadenectomy around the left renal vein (16a2lat) by tunneling under the pancreas for advanced Siewert type II adenocarcinoma. Surg Today 2016;46:1108-13. [PMID: 26482844 DOI: 10.1007/s00595-015-1264-6] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
344 Yamamoto M, Rashid OM, Wong J. Surgical management of gastric cancer: the East vs. West perspective. J Gastrointest Oncol. 2015;6:79-88. [PMID: 25642341 DOI: 10.3978/j.issn.2078-6891.2014.097] [Cited by in F6Publishing: 21] [Reference Citation Analysis]
345 Sawayama H, Iwatsuki M, Kuroda D, Toihata T, Uchihara T, Koga Y, Yagi T, Kiyozumi Y, Eto T, Hiyoshi Y, Ishimoto T, Baba Y, Miyamoto Y, Yoshida N, Baba H. The association of the lymph node ratio and serum carbohydrate antigen 19-9 with early recurrence after curative gastrectomy for gastric cancer. Surg Today 2018;48:994-1003. [PMID: 29926189 DOI: 10.1007/s00595-018-1684-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
346 Muilwijk T, Akand M, Gevaert T, Joniau S. No survival difference between super extended and standard lymph node dissection at radical cystectomy: what can we learn from the first prospective randomized phase III trial? Transl Androl Urol 2019;8:S112-5. [PMID: 31143684 DOI: 10.21037/tau.2018.12.09] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
347 Taniguchi Y, Kurokawa Y, Mikami J, Tanaka K, Miyazaki Y, Makino T, Takahashi T, Yamasaki M, Nakajima K, Takiguchi S, Mori M, Doki Y. Amylase concentration in drainage fluid as a predictive factor for severe postoperative pancreatic fistula in patients with gastric cancer. Surg Today. 2017;47:1378-1383. [PMID: 28365893 DOI: 10.1007/s00595-017-1521-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
348 Jiang L, Yao Z, Zhang Y, Hu J, Zhao D, Zhai H, Wang X, Zhang Z, Wang D. Comparison of lymph node number and prognosis in gastric cancer patients with perigastric lymph nodes retrieved by surgeons and pathologists. Chin J Cancer Res 2016;28:511-8. [PMID: 27877010 DOI: 10.21147/j.issn.1000-9604.2016.05.06] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
349 Seshadri RA, Glehen O. The Role of Hyperthermic Intraperitoneal Chemotherapy in Gastric Cancer. Indian J Surg Oncol 2016;7:198-207. [PMID: 27065710 DOI: 10.1007/s13193-016-0502-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
350 Taghavi S, Jayarajan SN, Davey A, Willis AI. Prognostic significance of signet ring gastric cancer. J Clin Oncol. 2012;30:3493-3498. [PMID: 22927530 DOI: 10.1200/jco.2012.42.6635] [Cited by in Crossref: 111] [Cited by in F6Publishing: 82] [Article Influence: 11.1] [Reference Citation Analysis]
351 Wang Y, Zhang L, Yang Y, Lu S, Chen H. Progress of Gastric Cancer Surgery in the era of Precision Medicine. Int J Biol Sci 2021;17:1041-9. [PMID: 33867827 DOI: 10.7150/ijbs.56735] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
352 Meng W, Gu T, Gao LM, Zong ZG, Meng L, Fu ZZ, Guo L. Correlation of cadherin-17 protein expression with clinicopathological features and prognosis of patients with sporadic gastric cancer. Braz J Med Biol Res 2015;48:1077-86. [PMID: 26421870 DOI: 10.1590/1414-431X20154645] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
353 Wei J, Yao T, Wang Y, Li L, Pan C, Zhang N. Prognostic analysis of stage III gastric cancer after curative surgery according to the newest TNM classification. Clin Transl Oncol 2019;21:232-8. [PMID: 29968135 DOI: 10.1007/s12094-018-1913-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
354 Kurokawa Y, Shibata T, Sasako M, Sano T, Tsuburaya A, Iwasaki Y, Fukuda H. Validity of response assessment criteria in neoadjuvant chemotherapy for gastric cancer (JCOG0507-A). Gastric Cancer. 2014;17:514-521. [PMID: 23999869 DOI: 10.1007/s10120-013-0294-2] [Cited by in Crossref: 40] [Cited by in F6Publishing: 45] [Article Influence: 4.4] [Reference Citation Analysis]
355 Li JQ, He D, Liang YX. Current status of extended 'D2 plus' lymphadenectomy in advanced gastric cancer. Oncol Lett 2021;21:467. [PMID: 33907577 DOI: 10.3892/ol.2021.12728] [Reference Citation Analysis]
356 Coccolini F, Montori G, Ceresoli M, Cima S, Valli MC, Nita GE, Heyer A, Catena F, Ansaloni L. Advanced gastric cancer: What we know and what we still have to learn. World J Gastroenterol 2016; 22(3): 1139-1159 [PMID: 26811653 DOI: 10.3748/wjg.v22.i3.1139] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 31] [Article Influence: 4.8] [Reference Citation Analysis]
357 Youn SI, Son SY, Lee K, Won Y, Min S, Park YS, Ahn SH, Kim HH. Quality of life after laparoscopic sentinel node navigation surgery in early gastric cancer: a single-center cohort study. Gastric Cancer 2021;24:744-51. [PMID: 33389274 DOI: 10.1007/s10120-020-01145-6] [Reference Citation Analysis]
358 Choi YY. The era of laparoscopic surgery for gastric cancer: what is the present territory and what will be next? Transl Gastroenterol Hepatol 2016;1:42. [PMID: 28138609 DOI: 10.21037/tgh.2016.05.03] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
359 Hashimoto T, Kurokawa Y, Mori M, Doki Y. Surgical Treatment of Gastroesophageal Junction Cancer. J Gastric Cancer 2018;18:209-17. [PMID: 30275998 DOI: 10.5230/jgc.2018.18.e28] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
360 Weledji EP. The principles of the surgical management of gastric cancer. Int J Surg Oncol (N Y) 2017;2:e11. [PMID: 29177225 DOI: 10.1097/IJ9.0000000000000011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
361 Crimì F, Bao QR, Mari V, Zanon C, Cabrelle G, Spolverato G, Pucciarelli S, Quaia E. Predictors of Metastatic Lymph Nodes at Preoperative Staging CT in Gastric Adenocarcinoma. Tomography 2022;8:1196-207. [DOI: 10.3390/tomography8030098] [Reference Citation Analysis]
362 Aoyama T, Yoshikawa T. Adjuvant therapy for locally advanced gastric cancer. Surg Today. 2017;47:1295-1302. [PMID: 28251375 DOI: 10.1007/s00595-017-1493-y] [Cited by in Crossref: 21] [Cited by in F6Publishing: 30] [Article Influence: 4.2] [Reference Citation Analysis]
363 Meyer HJ, Wilke H. Treatment strategies in gastric cancer. Dtsch Arztebl Int. 2011;108:698-705; quiz 706. [PMID: 22114638 DOI: 10.3238/arztebl.2011.0698] [Cited by in Crossref: 3] [Cited by in F6Publishing: 34] [Article Influence: 0.3] [Reference Citation Analysis]
364 Sakamoto Y, Sakaguchi Y, Sugiyama M, Minami K, Toh Y, Okamura T. Surgical indications for gastrectomy combined with distal or partial pancreatectomy in patients with gastric cancer. World J Surg 2012;36:2412-9. [PMID: 22699747 DOI: 10.1007/s00268-012-1681-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
365 Han WH, Joo J, Eom BW, Ryu KW, Kim YW, Kook MC, Yoon HM. Factors associated with metastasis in superior mesenteric vein lymph node in subtotal gastrectomy for gastric cancer: Retrospective case control study. Chin J Cancer Res 2020;32:43-50. [PMID: 32194304 DOI: 10.21147/j.issn.1000-9604.2020.01.06] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
366 Sendler A. [Tumors of the upper gastro-intestinal tract]. Chirurg 2010;81:103-6; 108-10. [PMID: 20076935 DOI: 10.1007/s00104-009-1813-x] [Reference Citation Analysis]
367 Giuliani A, Miccini M, Basso L. Extent of lymphadenectomy and perioperative therapies: Two open issues in gastric cancer. World J Gastroenterol 2014; 20(14): 3889-3904 [PMID: 24744579 DOI: 10.3748/wjg.v20.i14.3889] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]